,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic Thrombocytopenic Purpura, Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome, anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased lymphocytes, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, death, pneumonia, respiratory tract infection, pulmonary embolism, constipation, asthenia, nasopharyngitis, bronchitis, hypocalcemia, hyperglycemia, muscle spasms, peripheral neuropathies NEC, insomnia, rash, embolic and thrombotic events, venous, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, headache, dizziness, insomnia, dyspnea, epistaxis, renal failure, hypertension, dehydration, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, tumor lysis syndrome, posterior reversible encephalopathy syndrome."
1,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction, fatal outcome, myocardial ischemia, death, Acute Renal Failure, Tumor Lysis Syndrome (TLS), Acute Respiratory Distress Syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, Pulmonary Hypertension, Dyspnea, Hypertension, hypertensive crisis, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, Posterior reversible encephalopathy syndrome (PRES), Embryo-fetal Toxicity, congestive heart failure, pulmonary edema, decreased ejection fraction, restrictive cardiomyopathy, cardiac arrest, renal impairment, renal failure, pneumonitis, interstitial lung disease, Pulmonary arterial hypertension, deep venous thrombosis, pulmonary embolism, fever, chills, arthralgia, myalgia, facial flushing, facial edema, vomiting, weakness, shortness of breath, hypotension, syncope, chest tightness, angina, increased serum transaminases, seizure, headache, lethargy, confusion, blindness, altered consciousness, visual disturbances, neurological disturbances"
2,MULTAQ,adverse reactions,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, early increases in creatinine, QTc prolonged, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis"
3,MULTAQ,boxed warnings,"death, stroke, heart failure, hospitalization for heart failure, recent decompensation requiring hospitalization, NYHA Class IV heart failure, symptomatic heart failure"
4,MULTAQ,warnings and precautions,"AF, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, renal impairment, teratogen, cardiovascular death, heart failure, increased risk of stroke, new onset or worsening heart failure, hepatocellular liver injury, acute liver failure requiring transplant, interstitial lung disease, pneumonitis, pulmonary fibrosis, dyspnea, non-productive cough, QT interval prolongation, marked increase in serum creatinine, pre-renal azotemia, acute renal failure, death"
5,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
6,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, hypersensitivity, Serious Adverse Reactions, Adverse Reactions Leading to Discontinuation, Constipation, Vomiting, Increased transaminases, Hypokalemia, Phlebitis, Anemia, Eosinophilia, Neutropenia, Thrombocytopenia, Bradycardia, Palpitations, Abdominal pain, Pyrexia, Hepatitis, Anaphylaxis, Clostridium difficile colitis, Hyperglycemia, Hyperkalemia, Dizziness, Convulsion, Renal failure, Urticaria, Agranulocytosis"
7,TEFLARO,warnings and precautions,"serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), fatal colitis, Direct Coombs' test seroconversion, drug-induced hemolytic anemia, development of drug-resistant bacteria, death"
8,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
9,DATSCAN,warnings and precautions,"hypersensitivity reactions, anaphylactic, skin erythema, pruritis, thyroid neoplasia"
10,TIVICAY,adverse reactions,"Hypersensitivity reactions, Effects on serum liver biochemistries, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, Treatment-emergent Adverse Drug Reactions (ADRs), depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, attempt, behavior, completion, renal impairment, pruritus, laboratory abnormalities, ALT abnormalities, AST abnormalities, creatine kinase abnormalities, hyperglycemia, lipase abnormalities, total neutrophils abnormalities, elevated cholesterol, elevated HDL cholesterol, elevated LDL cholesterol, elevated triglycerides, elevated ALT, elevated AST, immune reconstitution syndrome, changes in serum creatinine, rash, abdominal pain"
11,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, life-threatening reaction, worsening of transaminase elevations, development of transaminase elevations, hepatotoxicity, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement, buffalo hump, peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, indolent or residual opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia, PCP, tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, death"
12,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, myalgia, cuSCC, cough, constipation, nasopharyngitis, hypophosphatemia, increased alkaline phosphatase, hyponatremia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased ALT, hyperbilirubinemia, increased GGT, hypoalbuminemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT Prolongation"
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, non-cutaneous malignancies, pancreatic adenocarcinoma, colorectal carcinoma, head and neck carcinoma, glioblastoma, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, fever, hypotension, rigors, chills, dehydration, renal failure, death"
14,HORIZANT,adverse reactions,"somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, asthenia, insomnia, breast enlargement, gynecomastia, elevated creatine kinase"
15,HORIZANT,warnings and precautions,"driving impairment, somnolence, sedation, dizziness, suicidal thoughts or behaviors, fatigue, asthenia, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), multiorgan hypersensitivity, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, withdrawal seizure, pancreatic acinar cell adenoma, carcinoma, death"
16,IMBRUVICA,adverse reactions,"hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, stomatitis, dyspepsia, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, hyperuricemia, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, subdural hematoma, sinusitis, urinary tract infection, chills, peripheral neuropathy, second malignancies, laceration, anxiety, insomnia, hypertension, contusion, vision blurred, gastroesophageal reflux disease, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema, death"
17,IMBRUVICA,warnings and precautions,"hemorrhage, bleeding, fatal bleeding events, Grade 3 or higher bleeding events, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, infections, fever, Grade 3 or greater infections, progressive multifocal leukoencephalopathy (PML), cytopenias, neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, arrhythmic symptoms, palpitations, lightheadedness, new onset dyspnea, second primary malignancies, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome, embryo-fetal toxicity, malformations, reduced fetal weights, death"
18,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, muscle twitching, muscle tightness, muscle weakness, musculoskeletal pain, musculoskeletal stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angioedema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, LDL increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure, jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior, aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, death."
19,ULORIC,warnings and precautions,"gout flare, cardiovascular thromboembolic events, myocardial infarction (MI), stroke, hepatic failure, fatal hepatic failure, transaminase elevations, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, drug-induced liver injury, death"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, herpes infections, lower respiratory tract infections, cellulitis, pyelonephritis, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, death"
21,CIMZIA,boxed warnings,"serious infections, hospitalization, death, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria, sepsis, lymphoma, malignancies"
22,CIMZIA,warnings and precautions,"serious infections, invasive fungal infections, lymphoma, other malignancies, heart failure, worsening or new onset, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, exacerbation or new onset, cytopenias, pancytopenia, lupus-like syndrome, tuberculosis reactivation, new tuberculosis infections, opportunistic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, hepatosplenic T-cell lymphoma (HSTCL), acute and chronic leukemia, worsening congestive heart failure (CHF), new onset CHF, hypersensitivity reactions, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, HBV reactivation, central nervous system demyelinating disease, multiple sclerosis, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, optic neuritis, peripheral neuropathy, aplastic anemia, leukopenia, thrombocytopenia, blood dyscrasias, death"
23,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, aspartate aminotransferase increased, blood glucose increased, hepatic enzyme increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne"
24,KALYDECO,warnings and precautions,"elevated transaminases, increased transaminase levels, non-congenital lens opacities, cataracts"
25,FULYZAQ,adverse reactions,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
26,FULYZAQ,warnings and precautions,"diarrhea, disease may worsen, infectious etiologies not considered, not receive the appropriate treatments, not receive the appropriate therapy"
27,QUTENZA,adverse reactions,"application-associated pain, increase in blood pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
28,QUTENZA,warnings and precautions,"coughing, sneezing, irritation of eyes, irritation of airway, transient increases in blood pressure, procedural pain, shortness of breath, treatment-related increases in pain, adverse cardiovascular effects"
29,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Capillary Leak Syndrome, Tumor Growth Stimulatory Effects on Malignant Cells, Bone Pain, Leukocytosis, Myalgia, Headache, Vomiting, Sweet's Syndrome, Cutaneous Vasculitis, Thrombocytopenia"
30,GRANIX,warnings and precautions,"Splenic Rupture, Acute Respiratory Distress Syndrome (ARDS), allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle cell crisis, Capillary Leak Syndrome (CLS), hypotension, hypoalbuminemia, edema, hemoconcentration, anaphylaxis, death"
31,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, rhinitis, aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption)"
32,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, cardiac arrhythmias, bradycardia, severe cardiac disease, sudden death, electrolyte balance disturbances, decreased efficacy, recrudescence, hepatic impairment, renal impairment, decreased exposure to lumefantrine, decreased bile production, increased plasma concentrations, adverse effects, loss of antimalarial efficacy, reduced effectiveness of hormonal contraceptives, relapsing malaria, Plasmodium vivax infection"
33,APTIOM,adverse reactions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, asthenia, rash, dysarthria, Gait disturbance, Peripheral edema, Urinary tract infections, Fall, Balance disorder, Memory impairment, Nystagmus, Depression, Insomnia, Cough, Hypertension, decreases in hemoglobin, decreases in hematocrit, increases in total cholesterol, increases in triglycerides, increases in LDL, increases in creatine phosphokinase"
34,APTIOM,warnings and precautions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Dizziness, Disturbance in Gait and Coordination, Somnolence, Fatigue, Cognitive Dysfunction, Visual Changes, Diplopia, Blurred Vision, Impaired Vision, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), Hepatitis, Nephritis, Hematological Abnormalities, Myocarditis, Myositis, Fever, Rash, Lymphadenopathy, Seizures, Nausea, Vomiting, Dehydration, Gait Instability, Injury, Hypochloremia, Ataxia, Vertigo, Balance Disorder, Gait Disturbance, Nystagmus, Abnormal Coordination, Asthenia, Malaise, Hypersomnia, Sedation, Lethargy, Memory Impairment, Disturbance in Attention, Amnesia, Confusional State, Aphasia, Speech Disorder, Slowness of Thought, Disorientation, Psychomotor Retardation, Drug Induced Liver Injury, Elevated Transaminases, Jaundice, Abnormal Thyroid Function Tests, Decreases in Serum T3 and T4, Death."
35,PROLIA,adverse reactions,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, pancreatitis, new malignancies, cataracts, drug-related hypersensitivity reactions, anaphylaxis, rash, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe musculoskeletal pain, marked elevation in serum PTH, death"
36,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, hospitalization, cellulitis, dermatologic reactions, dermatitis, rashes, eczema, severe bone pain, joint pain, muscle pain, suppression of bone turnover, death"
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, Anemia, Thrombocytopenia, Leukopenia, Diarrhea, Abdominal pain, Vomiting, Fatigue, Chills, Chest pain, Cytokine release syndrome, Other pathogen infections, Bacterial infections, Fungal infections, Viral infections, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased weight, Hypomagnesemia, Hyperglycemia, Decreased appetite, Hypophosphatemia, Back pain, Pain in extremity, Bone pain, Arthralgia, Dizziness, Insomnia, Cough, Dyspnea, Hypotension, Hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm, death."
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome, CRS, life-threatening, fatal, Neurological toxicities, severe, death"
39,BLINCYTO,warnings and precautions,"Infections, Effects on Ability to Drive and Use Machines, Preparation and Administration Errors, Cytokine Release Syndrome (CRS), Infusion reactions, Pyrexia, Headache, Nausea, Asthenia, Hypotension, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased total bilirubin, Disseminated intravascular coagulation (DIC), Capillary leak syndrome (CLS), Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), Neurological Toxicities, Encephalopathy, Convulsions, Speech disorders, Disturbances in consciousness, Confusion and disorientation, Coordination and balance disorders, Sepsis, Pneumonia, Bacteremia, Opportunistic infections, Catheter-site infections, Tumor Lysis Syndrome (TLS), Neutropenia, Febrile neutropenia, Loss of consciousness, Elevated Liver Enzymes, Transient elevations in liver enzymes, Grade 3 or greater elevations in liver enzymes, Leukoencephalopathy, death."
40,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, gastroenteritis viral, change in color vision, Non-arteritic anterior ischemic optic neuropathy (NAION), decreased vision, permanent loss of vision, death"
41,STENDRA,warnings and precautions,"hypotension, erection lasting greater than 4 hours, sudden loss of vision, Non Arteritic Ischemic Optic Neuropathy (NAION), sudden decrease or loss of hearing, tinnitus, dizziness, headache, myocardial infarction, stroke, life-threatening arrhythmia, coronary revascularization, resting hypotension, hypertension, unstable angina, angina with sexual intercourse, congestive heart failure, prolonged erection, priapism, penile tissue damage, permanent loss of potency, anatomical deformation of the penis, angulation, cavernosal fibrosis, Peyronie's disease, priapism, sickle cell anemia, multiple myeloma, leukemia, symptomatic hypotension, lightheadedness, fainting, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, bleeding disorders, active peptic ulceration, anti-aggregatory effect, sexually transmitted diseases, Human Immunodeficiency Virus (HIV)"
42,XIAFLEX,adverse reactions,"tendon ruptures, serious injury to the injected extremity, corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, pruritus, lymphadenopathy, axillary mass, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, injection site swelling, ecchymosis, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, immunogenicity"
43,XIAFLEX,boxed warnings,"Corporal rupture, Penile fracture, Serious penile injury, Penile ecchymoses, Hematoma, Sudden penile detumescence, Penile ""popping"" sound, Penile ""popping"" sensation, Severe penile hematoma, Death"
44,XIAFLEX,warnings and precautions,"tendon rupture, serious injury, injected finger/hand injury, permanent injury, ligament damage, skin laceration, corporal rupture (penile fracture), serious injury to the penis, hypersensitivity reactions, anaphylaxis, abnormal coagulation, flexor tendon ruptures, damage to collagen-containing structures, pulley rupture, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin tear, penile ecchymoses, penile hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, allergic reactions, pruritus, IgE-anti-drug antibodies, ecchymosis/contusion, injection site hemorrhage, bleeding, coagulation disorders."
45,XEOMIN,adverse reactions,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, eye disorders, blepharospasm, eye disorder, sensation of pressure, facial pain, immunogenicity, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia, hypersensitivity"
46,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
47,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, concomitant neuromuscular disorders, corneal exposure, ulceration, reduced blinking, corneal ulceration, corneal perforation, diplopia, ptosis, asthenia, generalized muscle weakness, blurred vision, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, hypersensitivity reactions, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, respiratory failure, aspiration, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junctional disorders, severe dysphagia, respiratory compromise, ectropion, narrow angle glaucoma, ecchymosis"
48,GILOTRIF,adverse reactions,"diarrhea, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, bullous skin disorders, exfoliative skin disorders, interstitial lung disease, hepatic toxicity, keratitis, dyspnea, fatigue, hypokalemia, pulmonary toxicity, ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, cheilitis, cystitis, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, alanine aminotransferase increased, aspartate aminotransferase increased, pancreatitis, death"
49,GILOTRIF,warnings and precautions,"diarrhea, dehydration, renal failure, severe diarrhea, prolonged diarrhea, bullous skin disorders, exfoliative skin disorders, blistering lesions, exfoliating lesions, life-threatening cutaneous reactions, severe cutaneous reactions, prolonged cutaneous reactions, interstitial lung disease (ILD), lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, hepatic toxicity, fatal hepatic impairment, liver test abnormalities, keratitis, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, ulcerative keratitis, severe dry eye, embryofetal toxicity, fetal harm, abortions, death"
50,TREANDA,adverse reactions,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, malaise, weakness, dry mouth, somnolence, mucosal inflammation, hypertension, hypertensive crisis, hypersensitivity, gastrointestinal disorders, diarrhea, general disorders, administration site conditions, immune system disorders, infections and infestations, nasopharyngitis, herpes simplex, investigations, metabolism and nutrition disorders, hyperuricemia, respiratory disorders, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, pruritus, hematology laboratory abnormalities, increased bilirubin, increased AST, increased ALT, changes in creatinine levels, cardiac disorders, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal pain upper, abdominal distension, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, febrile neutropenia, oral candidiasis, weight decreased, dehydration, decreased appetite, hypokalemia, musculoskeletal and connective tissue disorders, back pain, arthralgia, pain in extremity, bone pain, nervous system disorders, dizziness, dysgeusia, psychiatric disorders, insomnia, anxiety, depression, pharyngolaryngeal pain, wheezing, nasal congestion, dry skin, night sweats, hyperhidrosis, vascular disorders, hypotension, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, injection or infusion site reactions, phlebitis, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)"
51,TREANDA,warnings and precautions,"myelosuppression, death, infections, fever, anaphylaxis, infusion reactions, tumor lysis syndrome, acute renal failure, skin reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), pre-malignant diseases, malignant diseases, extravasation injury, erythema, swelling, pain, embryo-fetal toxicity, neutropenic sepsis, diffuse alveolar hemorrhage, thrombocytopenia, pneumonia, opportunistic infection (CMV), septic shock, pruritus, rash, allergic-type reactions, bullous exanthema, myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, infection, necrosis, resorptions, skeletal malformations, visceral malformations, decreased fetal body weights"
52,CHOLINE,adverse reactions,injection site reaction
53,CHOLINE,warnings and precautions,"imaging errors, blood PSA levels < 2 ng/mL, poor imaging performance, allergic reactions, anaphylaxis, radiation risk, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, increased risk for cancer"
54,ERWINAZE,adverse reactions,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergic reactions, coagulopathy, hyperlipidemia, ketoacidosis, CNS events, hepatobiliary disorders, pancreatic disorders, anti-drug antibodies (ADA)"
55,ERWINAZE,warnings and precautions,"serious hypersensitivity reactions, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
56,TRULICITY,adverse reactions,"Risk of Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, dyspepsia, fatigue, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, sinus tachycardia, systemic hypersensitivity, severe urticaria, systemic rash, facial edema, lip swelling, injection-site rash, erythema, PR Interval Prolongation, first degree Atrioventricular (AV) Block, Amylase increase, Lipase increase"
57,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
58,TRULICITY,warnings and precautions,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, severe gastrointestinal reactions, death"
59,ADREVIEW,adverse reactions,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
60,ADREVIEW,warnings and precautions,"hypersensitivity reactions, anaphylactic, withdrawal signs and symptoms, serious reactions, increased radiation exposure, decreased quality of AdreView images, iodine 123 accumulation, toxicity (hypotension, metabolic acidosis), kernicterus, death, Gasping Syndrome, decreased cardiac uptake, transient episode of hypertension"
61,DOTAREM,adverse reactions,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis, death"
62,DOTAREM,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, Chronic severe kidney disease, Acute kidney injury, reduced renal function, death"
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, impaired elimination of GBCAs, Hypersensitivity, Anaphylactoid reactions, anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, severe reactions, death, acute kidney injury, drug-induced kidney toxicity, NSF, fatal fibrosis, debilitating fibrosis, circulatory collapse, allergic disorders, bronchial asthma, Acute Kidney Injury requiring dialysis, tissue irritation, Extravasation, Injection Site Reactions"
64,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, dyspepsia, nausea, upper abdominal pain, diarrhea, hemorrhagic stroke, intracranial hemorrhage, subarachnoid bleeds, subdural bleeds, gastrointestinal bleeds, major bleeding, fatal bleeding, intracerebral bleeding, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, myocardial infarction, abdominal pain upper, abdominal discomfort, epigastric discomfort, angioedema, thrombocytopenia, esophageal ulcer, death"
65,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, pathological bleeding, long-term paralysis, permanent paralysis, neurological impairment, death"
66,PRADAXA,warnings and precautions,"bleeding, serious bleeding, fatal bleeding, thrombotic events, blood loss, hypotension, active pathological bleeding, renal impairment, epidural hematoma, spinal hematoma, paralysis, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions, neurological impairment, midline back pain, sensory deficits, motor deficits, numbness, tingling, weakness in lower limbs, bowel dysfunction, bladder dysfunction, death"
67,ELIQUIS,adverse reactions,"thrombotic events, bleeding, spinal/epidural anesthesia or puncture, hemorrhagic stroke, gastrointestinal bleed, fatal, intracranial bleed, hypersensitivity reactions, skin rash, anaphylactic reactions, allergic edema, syncope, nausea, anemia, contusion, hemorrhage, hematoma, vaginal hemorrhage, urethral hemorrhage, postprocedural hemorrhage, wound hemorrhage, vessel puncture site hematoma, catheter site hemorrhage, transaminases increased, alanine aminotransferase increased, alanine aminotransferase abnormal, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, platelet count decreases, hypotension, procedural hypotension, epistaxis, gastrointestinal hemorrhage, hematemesis, melena, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, incision-site hematoma, operative hemorrhage, gingival bleeding, hemoptysis, muscle hemorrhage, ocular hemorrhage, conjunctival hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, traumatic hematoma, periorbital hematoma, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma, death"
68,ELIQUIS,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term paralysis, permanent paralysis"
69,ELIQUIS,warnings and precautions,"serious bleeding, fatal bleeding, blood loss, thrombotic events, stroke, increased risk of bleeding, pathological bleeding, active pathological hemorrhage, epidural hematoma, spinal hematoma, long-term paralysis, permanent paralysis, neurological impairment, numbness, weakness of the legs, bowel dysfunction, bladder dysfunction, death"
70,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, death, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, dyspnea, urticaria, venous thrombosis"
71,ZERBAXA,warnings and precautions,"decreased efficacy, serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), mild diarrhea, fatal colitis, development of drug-resistant bacteria, death"
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
73,FERRIPROX,boxed warnings,"agranulocytosis, neutropenia, serious infections, death, infection"
74,FERRIPROX,warnings and precautions,"infection, fetal harm, agranulocytosis, neutropenia, death, increased ALT values, increased serum ALT levels, increased AST levels, decreased plasma zinc concentrations"
75,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, ALT elevations"
76,DALVANCE,warnings and precautions,"serious hypersensitivity, anaphylactic reactions, skin reactions, rapid intravenous infusion reactions, ALT elevations, Clostridium difficile-associated diarrhea (CDAD), Red-Man Syndrome, flushing of the upper body, urticaria, pruritus, rash, liver test abnormalities, AST elevation, bilirubin elevation, mild diarrhea, fatal colitis, morbidity, mortality, fluid and electrolyte imbalance, protein supplementation needs, surgical evaluation, development of drug-resistant bacteria, death"
77,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, death"
78,ARCAPTA,boxed warnings,"asthma-related death, death"
79,ARCAPTA,warnings and precautions,"acute symptoms, cardiovascular effects, fatal, death, immediate hypersensitivity reactions, paradoxical bronchospasm, life-threatening, clinically significant cardiovascular effects, fatalities, difficulties in breathing, swallowing, swelling of tongue, lips and face, urticaria, skin rash, increases in pulse rate, systolic or diastolic blood pressure, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, convulsive disorders, thyrotoxicosis, aggravate pre-existing diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, asthma-related death, serious asthma-related events, deterioration of disease, excessive use of ARCAPTA NEOHALER, use with other long-acting beta2-agonists, overdose, allergic reactions, cardiovascular disorders, coronary insufficiency, cardiac arrhythmias, hypertension, convulsive disorders, thyrotoxicosis, sympathomimetic amines, intracellular shunting, adverse cardiovascular effects, serum potassium decrease, plasma glucose increases, diabetes mellitus not well controlled."
80,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
81,CERDELGA,warnings and precautions,"ECG Changes, Cardiac Arrhythmias, prolongation of the PR interval, prolongation of the QTc interval, prolongation of the QRS interval, congestive heart failure, acute myocardial infarction, bradycardia, heart block, ventricular arrhythmia, long QT syndrome"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, death"
83,GADAVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, Chronic severe kidney disease, Acute kidney injury, reduced renal function, death."
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, Anaphylactic reactions, Hypersensitivity reactions, Cardiovascular manifestations, Respiratory manifestations, Cutaneous manifestations, Death, Acute Kidney Injury, Extravasation, Injection Site Reactions, Overestimation of Extent of Malignant Disease"
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, vision disorder, prolonged QT interval, hemoglobin decreased, alanine transaminase increased, aspartate transaminase increased, creatinine increased, glucose increased, phosphate decreased, lipase increased, bilirubin increased, death"
86,ZYKADIA,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, Interstitial Lung Disease (ILD), pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Embryofetal Toxicity, elevated transaminases, jaundice, ventricular tachyarrhythmias, Torsade de pointes, sudden death, sinus bradycardia, skeletal anomalies, death"
87,XALKORI,adverse reactions,"hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, bradycardia, severe visual loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, death, abdominal pain, pyrexia, weight increased, pain in extremity, muscle spasm, dizziness, headache, fatigue, neuropathy, gait disturbance, hypoaesthesia, muscular weakness, neuralgia, neuropathy peripheral, paraesthesia, peripheral sensory neuropathy, polyneuropathy, sensory disturbance, rash, renal cyst, syncope, hypophosphatemia, neutropenia, lymphopenia, ALT elevation, AST elevation, acute respiratory distress syndrome, arrhythmia, pneumonia, respiratory failure, sepsis, hypokalemia, hepatic failure, dysesthesia, burning sensation in skin."
88,XALKORI,warnings and precautions,"hepatotoxicity, fatal hepatotoxicity, death, Interstitial Lung Disease, ILD, Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, concurrent elevations in alanine aminotransferase, concurrent elevations in aspartate aminotransferase, elevated transaminases, elevated total bilirubin, severe visual loss, optic atrophy, optic nerve disorder, embryotoxicity, fetotoxicity"
89,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
90,BEPREVE,warnings and precautions,"contamination, contact lens-related irritation"
91,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, abnormal platelet counts, abnormal WBC counts, rash, pruritus, angioedema"
92,EDARBI,boxed warnings,"fetal toxicity, injury, death"
93,EDARBI,warnings and precautions,"fetal toxicity, fetal renal function reduction, fetal and neonatal morbidity, death, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, symptomatic hypotension, transient hypotensive response, changes in renal function, oliguria, progressive azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen"
94,POTIGA,adverse reactions,"Retinal abnormalities, potential vision loss, Urinary retention, Skin discoloration, Neuropsychiatric symptoms, Dizziness, Somnolence, QT interval effect, Suicidal behavior, ideation, Withdrawal seizures, Fatigue, Confusional state, Vertigo, Tremor, Abnormal coordination, Diplopia, Disturbance in attention, Memory impairment, Asthenia, Blurred vision, Gait disturbance, Aphasia, Dysarthria, Balance disorder, Nausea, Constipation, Dyspepsia, Influenza, Weight increased, Paresthesia, Amnesia, Dysphasia, Anxiety, Disorientation, Psychotic disorder, Dysuria, Urinary hesitation, Hematuria, Chromaturia, Increased appetite, Hallucinations, Myoclonus, Peripheral edema, Hypokinesia, Dry mouth, Dysphagia, Hyperhydrosis, Malaise, Increased liver enzymes, Rash, Nystagmus, Dyspnea, Leukopenia, Muscle spasms, Alopecia, Nephrolithiasis, Syncope, Neutropenia, Thrombocytopenia, Euphoric mood, Renal colic, Coma, Encephalopathy, death"
95,POTIGA,boxed warnings,"retinal abnormalities, potential vision loss, damage to the photoreceptors, vision loss, abnormal visual acuity, decreased visual acuity, retinal pigmentary abnormalities, vision changes"
96,POTIGA,warnings and precautions,"urinary retention, skin discoloration, neuropsychiatric symptoms, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts or behaviors, suicidal ideation, retinal abnormalities, potential vision loss, vision changes, perivascular pigmentation, retinal pigment epithelium clumping, abnormal visual acuity, retinal dystrophy, abnormal electroretinogram, abnormal electrooculogram, abnormal fluorescein angiography, diminished sensitivity on visual field testing, hydronephrosis, renal function impairment, urinary hesitation, dysuria, blue skin discoloration, grey-blue skin discoloration, brown skin discoloration, nail discoloration, lip discoloration, mucous membrane discoloration, palate discoloration, scleral discoloration, conjunctiva discoloration, psychosis, withdrawal seizures"
97,TUDORZA,adverse reactions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching, death"
98,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, angioedema, anaphylaxis, bronchospasm, urticaria, rash, itching"
99,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, abdominal pain, toothache, vitamin D deficiency, dyspnea, pain in extremity, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, Thrombotic microangiopathy with acute renal failure"
100,PROMACTA,boxed warnings,hepatic decompensation
101,PROMACTA,warnings and precautions,"hepatotoxicity, Monitor liver function, Thrombotic/Thromboembolic Complications, Portal vein thrombosis, hepatic decompensation, ascites, encephalopathy, liver enzyme elevations, serum ALT, AST, bilirubin elevation, indirect hyperbilirubinemia, increased direct bilirubin, clinical symptoms of liver injury, hepatic decompensation, thrombotic event, venous events, arterial events, Factor V Leiden, ATIII deficiency, antiphospholipid syndrome, chronic liver disease, thromboembolism, abdominal pain, nausea, vomiting, diarrhea, cataracts"
102,INLYTA,adverse reactions,"hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS (reversible posterior leukoencephalopathy syndrome), proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia (hand-foot) syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes (absolute) decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP (alkaline phosphatase) increased, hyperglycemia, amylase increased, ALT (alanine aminotransferase) increased, AST (aspartate aminotransferase) increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia"
103,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, thyroid hormone replacement, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), proteinuria, liver enzyme elevation, hepatic impairment, fetal harm, death"
104,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia, Confusion, Ischemic Heart Disease, Arrhythmias, Congestive Heart Failure, Headache, Dizziness, Nausea, Hypertension, Fatigue, Increased Blood Pressure, Falls, Urinary Tract Infections, Syncope"
105,NORTHERA,boxed warnings,supine hypertension
106,NORTHERA,warnings and precautions,"supine hypertension, cardiovascular risk, hyperpyrexia, confusion, exacerbate symptoms, ischemic heart disease, arrhythmias, congestive heart failure, allergic reactions, bronchial asthma, death"
107,JARDIANCE,adverse reactions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased low-density lipoprotein cholesterol (LDL-C), increased urination, dyslipidemia, arthralgia, nausea, thirst, volume depletion, blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, hypovolemia, orthostatic hypotension, syncope, polyuria, pollakiuria, nocturia, serum creatinine increased, eGFR decreased, genital infection fungal, vulvovaginal candidiasis, vulvitis, vaginal infection, balanoposthitis, balanitis, scrotal abscess, penile infection, asymptomatic bacteriuria, cystitis, phimosis, increase in hematocrit"
108,JARDIANCE,warnings and precautions,"hypotension, renal impairment, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C"
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, anemia, iron deficiency anemia, leukopenia, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation"
110,FANAPT,boxed warnings,"increased mortality, death, cardiovascular events, heart failure, sudden death, infectious events, pneumonia"
111,FANAPT,warnings and precautions,"death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, hyperglycemia, diabetes mellitus, polydipsia, polyuria, polyphagia, weakness, dyslipidemia, weight gain, seizures, orthostatic hypotension, dizziness, tachycardia, syncope, leukopenia, neutropenia, agranulocytosis, suicide, priapism, cognitive impairment, motor impairment, somnolence, sedation"
112,TANZEUM,adverse reactions,"Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Upper respiratory tract infection, Diarrhea, Nausea, Injection site reaction, Cough, Back pain, Arthralgia, Sinusitis, Influenza, Vomiting, Gastroesophageal reflux disease, Dyspepsia, Constipation, Injection site hematoma, Injection site erythema, Injection site rash, Injection site hypersensitivity, Injection site hemorrhage, Injection site pruritus, Pneumonia, Atrial fibrillation, Atrial flutter, Appendicitis, Immunogenicity, Anti-albiglutide antibodies, Anti-GLP-1 antibodies, Antibodies to human albumin, Liver Enzyme Abnormalities, Alanine aminotransferase (ALT) increase, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase"
113,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
114,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Acute Pancreatitis, Serious Hypersensitivity Reaction, Pruritus, Rash, Dyspnea, Acute Renal Failure, Worsening of Chronic Renal Failure, Nausea, Vomiting, Diarrhea, Dehydration"
115,EYLEA,adverse reactions,"endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal detachment, retinal tear, death"
116,EYLEA,warnings and precautions,"endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, death"
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, arrhythmia, dyspepsia, peripheral edema, mucosal inflammation, pain, urinary tract infection, weight decreased, dehydration, muscle spasms, dizziness, headache, dysuria, hypotension, sepsis, septic shock, increased AST, increased ALT, increased bilirubin, gastritis, intestinal obstruction, death."
118,JEVTANA,boxed warnings,"neutropenia, hypersensitivity, neutropenic deaths, death, generalized rash, erythema, hypotension, bronchospasm"
119,JEVTANA,warnings and precautions,"bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, hypersensitivity reactions, severe hypersensitivity reactions, gastrointestinal disorders, nausea, vomiting, diarrhea, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis, renal failure, death, fetal harm, embryotoxic, fetotoxic, abortifacient, anemia, thrombocytopenia, pancytopenia, neutropenic deaths, infectious adverse events, sepsis, septic shock, Grade 3-4 neutropenia, generalized rash/erythema, hypotension, bronchospasm, diarrhea and electrolyte imbalance, GI hemorrhage, ileus, enterocolitis, abdominal pain, tenderness, fever, persistent constipation, obstructive uropathy."
120,YERVOY,adverse reactions,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), hypersensitivity, anaphylaxis, death"
121,YERVOY,boxed warnings,"immune-mediated adverse reactions, enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy, severe immune-mediated reactions, death"
122,YERVOY,warnings and precautions,"severe immune-mediated reactions, fatal immune-mediated reactions, moderate immune-mediated adverse reactions, immune-mediated hepatitis, immune-mediated endocrinopathies, immune-mediated enterocolitis, severe enterocolitis, life-threatening enterocolitis, fatal enterocolitis, moderate enterocolitis, intestinal perforation, complications, severe enterocolitis, diarrhea, fever, ileus, peritoneal signs, abdominal pain, mucus or blood in stool, hepatotoxicity, fatal hepatic failure, liver function test abnormalities, immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash complicated by full thickness dermal ulceration, necrotic manifestations, bullous manifestations, hemorrhagic manifestations, dermatitis, pruritus, immune-mediated neuropathies, fatal Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, Guillain-Barre syndrome, motor or sensory neuropathy, weakness, sensory alterations, paresthesia, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, fatigue, headache, mental status changes, abdominal pain, unusual bowel habits, hypotension, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, death."
123,FARXIGA,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Nasopharyngitis, Urinary Tract Infections, Back Pain, Increased Urination, Male Genital Mycotic Infections, Nausea, Influenza, Dyslipidemia, Constipation, Discomfort with Urination, Pain in Extremity, Volume Depletion, Dehydration, Hypovolemia, Orthostatic Hypotension, Renal Failure, Blood Creatinine Increase, Bone Fractures, Hypersensitivity Reactions, Angioedema, Urticaria, Anaphylactic Reactions, Severe Cutaneous Adverse Reactions, Increase in Hematocrit, Increase in Serum Inorganic Phosphorus, Hyperphosphatemia."
124,FARXIGA,warnings and precautions,"hypotension, volume contraction, symptomatic hypotension, impairment in renal function, increased serum creatinine, decreased eGFR, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer, hematuria"
125,PICATO,adverse reactions,"local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
126,PICATO,warnings and precautions,"eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, vesiculation/pustulation, erosion/ulceration, erythema, crusting, swelling, anaphylaxis, allergic contact dermatitis"
127,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts and Behaviors, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, Blood pressure increased, Dry mouth, Vomiting, Fatigue, Chills, Feeling jittery, Decreased appetite, Tremor, Disturbance in attention, Insomnia, Nervousness, Abnormal dreams, Urinary hesitation, Yawning, Vision blurred, Mydriasis, Vertigo, Tinnitus, Dysgeusia, Hot flush, Anorgasmia, Libido decreased, Orgasm abnormal, Ejaculation delayed, Erectile dysfunction, Ejaculation disorder, Ejaculation failure, Sexual dysfunction, Tachycardia, Asthenia, Weight increased, liver function test abnormal, blood prolactin increased, Musculoskeletal stiffness, Syncope, convulsion, dystonia, Depersonalization, bruxism, Urinary retention, Rash, alopecia, photosensitivity reaction, angioedema, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, Lipid abnormalities (Total Cholesterol, LDL Cholesterol, Triglycerides), Proteinuria, Blood pressure changes (Supine systolic bp, Supine diastolic bp, Pulse rate), Weight changes, Sustained hypertension, Orthostatic hypotension, Stevens-Johnson syndrome."
128,PRISTIQ,boxed warnings,"suicidal thoughts, suicidal behaviors, worsening, emergence of suicidal thoughts, emergence of suicidal behaviors"
129,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, suicidal thoughts, suicidal behaviors, suicidality, unusual changes in behavior, serotonin syndrome, elevated blood pressure, hypertension, abnormal bleeding, bleeding events, angle closure glaucoma, activation of mania, hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, psychomotor restlessness, dizziness, diaphoresis, flushing, hyperthermia, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, gastrointestinal symptoms, nausea, vomiting, diarrhea, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, dysphoric mood, sensory disturbances, paresthesia, electric shock sensations, confusion, headache, lethargy, emotional lability, tinnitus, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, coma, respiratory arrest, death, progressive dyspnea, cough, chest discomfort."
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation, suicide attempt, death, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, peripheral neuritis, neuropathy, anxiety, increased cough, rhinitis, Skin discoloration, Proteinuria, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, AST, ALT, gamma GT, rhabdomyolysis, osteomalacia, bone pain, fractures, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, increased creatinine, polyuria, asthenia"
131,STRIBILD,boxed warnings,"lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B, death"
132,STRIBILD,warnings and precautions,"new onset or worsening renal impairment, acute renal failure, Fanconi syndrome, lactic acidosis, severe hepatomegaly with steatosis, death, severe acute exacerbations of hepatitis B, liver decompensation, liver failure, renal impairment, proximal renal tubular dysfunction, renal replacement therapy, bone pain, pain in extremities, fractures, muscular pain, weakness, decreases in bone mineral density (BMD), redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, inflammatory response, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
133,NULOJIX,adverse reactions,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, bacterial infections, mycobacterial infections, viral infections, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion reactions, hypotension, hypertension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, hyperkalemia, hypophosphatemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, dysuria, renal tubular necrosis, cough, dyspnea, blood creatinine increased, arthralgia, back pain, headache, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation, death"
134,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder, central nervous system involvement, malignancies, serious infections, increased susceptibility to infection, graft loss, death"
135,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), new or worsening neurological signs and symptoms, cognitive signs and symptoms, behavioral signs and symptoms, other malignancies, skin malignancies, Progressive Multifocal Leukoencephalopathy (PML), serious infections, bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, Polyoma virus-associated nephropathy (PVAN), kidney graft loss, liver transplant not recommended, graft loss, death, acute rejection, Grade III rejection, increased risk of infections, cytomegalovirus (CMV) infection, herpes infection, Pneumocystis jiroveci infection, deteriorating renal function, avoidance of live vaccines."
136,LUMIZYME,adverse reactions,"hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, supraventricular tachycardia, local swelling, diarrhea, pruritus, edema, peripheral, rash papular, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, death"
137,LUMIZYME,boxed warnings,"anaphylaxis, hypersensitivity reactions, immune-mediated reactions, cardiorespiratory failure, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload, acute exacerbation of cardiac or respiratory compromise"
138,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, life-threatening, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, chest discomfort, chest pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension, increased blood pressure, flushing, feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, immune-mediated reactions, necrotizing skin lesions, type III immune-mediated reactions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, acute cardiorespiratory failure, cardiac hypertrophy, fluid overload, cardiac arrhythmia, sudden cardiac death, general anesthesia complications, ventricular arrhythmias, bradycardia, cardiac resuscitation, defibrillation, antibody development, reduced clinical efficacy, loss of motor function, ventilator dependence, death"
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus, rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
140,EOVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal, debilitating fibrosis affecting the skin, muscle and internal organs, Chronic, severe kidney disease, Acute kidney injury, death"
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, Hypersensitivity, anaphylactoid reactions, hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, shock, death, acute kidney injury, NSF, fibrosis affecting the skin, fibrosis affecting muscle, fibrosis affecting internal organs, rapid decrease in kidney function, drug-induced kidney toxicity, Extravasation, Injection Site Reactions, local tissue reactions, myocyte necrosis, inflammation, falsely high serum iron values, falsely low serum iron values, reduced hepatic contrast, severe renal failure, severe hepatic failure, elevated serum ferritin levels, high serum bilirubin"
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, death, hepatic failure, ventricular fibrillation, febrile neutropenia"
143,BELEODAQ,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, serious infections, fatal infections, pneumonia, sepsis, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, nausea, vomiting, diarrhea, embryo-fetal toxicity, fetal harm, teratogenicity, embryo-fetal lethality, death"
144,VICTRELIS,adverse reactions,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, diarrhea, vomiting, dry mouth, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma"
145,VICTRELIS,warnings and precautions,"Embryofetal Toxicity, birth defects, fetal death, death, Anemia, decrease in hemoglobin concentrations, Neutropenia, worsening of neutropenia, Hypersensitivity, serious acute hypersensitivity reactions, urticaria, angioedema, dyspnea, exertional dyspnea, dizziness, syncope, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, Pancytopenia"
146,VIMIZIM,adverse reactions,"anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, immunogenicity, anti-drug antibodies, neutralizing antibodies"
147,VIMIZIM,boxed warnings,"anaphylaxis, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, hypersensitivity reactions, acute respiratory illness, serious acute exacerbation of respiratory compromise, death"
148,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute respiratory complications, sleep apnea, spinal or cervical cord compression, back pain, paralysis, urinary incontinence, fecal incontinence, death"
149,SIRTURO,adverse reactions,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, Nausea, Arthralgia, Headache, Hemoptysis, Chest Pain, Anorexia, Transaminases Increased, Rash, Blood Amylase Increased, death"
150,SIRTURO,boxed warnings,"Increased Mortality, death, QT Prolongation, significant ventricular arrhythmia"
151,SIRTURO,warnings and precautions,"QT prolongation, significant ventricular arrhythmia, QTcF interval > 500 ms, Hepatotoxicity, liver injury, increased mortality, death, Clinically significant ventricular arrhythmia, syncope, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations, total bilirubin elevation, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, serum calcium deficiency, serum magnesium deficiency, serum potassium deficiency"
152,NEURACEQ,adverse reactions,"erythema, irritation, pain"
153,NEURACEQ,warnings and precautions,"Image interpretation errors, false positives, long-term cumulative radiation exposure, increased risk of cancer, unintentional radiation exposure, errors in brain neuritic beta-amyloid plaque density estimation, errors from severe brain atrophy, errors due to motion artifacts, image distortion."
154,COMETRIQ,adverse reactions,"Perforations, Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, asthenia, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, dysgeusia, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hypomagnesemia, hypokalemia, hyponatremia, pneumonia, septicemia, cardiac arrest, respiratory failure, death, vomiting, dysphagia, dyspepsia, hemorrhoids, pancreatitis, tracheal fistula formation, increased lipase, PPES, hair color changes/depigmentation/graying, increased TSH."
155,COMETRIQ,boxed warnings,"perforations, fistulas, gastrointestinal perforations, fistula formation, hemorrhage, severe hemorrhage, fatal hemorrhage, hemoptysis, gastrointestinal hemorrhage, death"
156,COMETRIQ,warnings and precautions,"myocardial infarction, cerebral infarction, arterial thromboembolic events, dehiscence, wound complications, hypertensive crisis, osteonecrosis of the jaw, Palmar-plantar Erythrodysesthesia syndrome (PPES), Proteinuria, nephrotic syndrome, Reversible posterior leukoencephalopathy syndrome (RPLS), Gastrointestinal (GI) perforations, fistulas, tracheal/esophageal fistulas, hemorrhage, hemoptysis, venous thromboembolism, arterial thromboembolism, hypertension, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, seizures, headache, visual disturbances, confusion, altered mental function, embryofetal toxicity, fetal harm, skeletal variations, visceral variations, malformations, death"
157,AFINITOR,adverse reactions,"Non-infectious pneumonitis, Infections, Angioedema, Oral ulceration, Renal failure, Impaired wound healing, Stomatitis, Rash, Fatigue, Diarrhea, Edema, Abdominal pain, Nausea, Fever, Asthenia, Cough, Headache, Decreased appetite, Hypercholesterolemia, Hyperglycemia, Increased aspartate transaminase (AST), Anemia, Leukopenia, Thrombocytopenia, Lymphopenia, Increased alanine transaminase (ALT), Hypertriglyceridemia, Death, Hemoglobin decreased, WBC decreased, Platelets decreased, Lymphocytes decreased, Neutrophils decreased, Glucose increased, Cholesterol increased, Aspartate transaminase (AST) increased, Alanine transaminase (ALT) increased, Triglycerides increased, Albumin decreased, Potassium decreased, Creatinine increased, Hematology, Clinical chemistry, Hypercholesterolemia, Hypertriglyceridemia, Hypophosphatemia, Alkaline phosphatase increased, Elevated aspartate transaminase (AST), Elevated alanine transaminase (ALT), Fasting hyperglycemia, Vomiting, Constipation, Dry mouth, Peripheral edema, Upper respiratory tract infection, Arthralgia, Acne, Amenorrhea, Menorrhagia, Menstrual irregularities, Vaginal hemorrhage, Epistaxis, Decreased appetite, Otitis media, Depression, Abnormal taste, Increased blood luteinizing hormone (LH) levels, Increased blood follicle stimulating hormone (FSH) levels, Hypersensitivity, Ovarian cyst, Pneumonitis, Angioedema, Leucopenia, Neutropenia, Thrombocytopenia, Elevated partial thromboplastin time, Neutropenia, Anemia, Elevated aspartate transaminase (AST), Hypertriglyceridemia, Elevated alanine transaminase (ALT), Hypophosphatemia, Pyrexia, Pneumonia, Gastroenteritis, Aggression, Agitation, Rash, Anxiety, Panic attack, Abnormal behavior, Obsessive compulsive disorder, Dermatitis allergic, Urticaria, Pain in extremity, Insomnia, Pneumonia, Hypersensitivity, Increased blood luteinizing hormone (LH) levels, Pneumonitis, Cellulitis, Hyperglycemia, Elevated creatinine, Acute pancreatitis, Cholecystitis, Cholelithiasis, Arterial thrombotic events, Reflex sympathetic dystrophy."
158,AFINITOR,warnings and precautions,"non-infectious pneumonitis, fatal cases, infections, fatal infections, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, death, impaired wound healing, wound-related complications, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, laboratory test alterations, serum creatinine elevations, urinary protein elevations, blood glucose elevations, lipid elevations, hemoglobin decreases, neutrophils decreases, platelets decreases, vaccinations avoidance, embryo-fetal toxicity, fetal harm, geriatric deaths, geriatric adverse reactions, hyperglycemia, hyperlipidemia, hypertriglyceridemia, decreased hemoglobin, lymphocytes, neutrophils, platelets, drug-drug interactions, hepatic impairment, pneumonia, mycobacterial infections, bacterial infections, invasive fungal infections, aspergillosis, candidiasis, pneumocystis jiroveci pneumonia (PJP), viral infections, hepatitis B virus reactivation, sepsis, respiratory failure, hepatic failure"
159,BREO,adverse reactions,"asthma-related death, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, death"
160,BREO,boxed warnings,"asthma-related death, increase in asthma-related deaths, asthma-related hospitalization, death"
161,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, overdose, Candida albicans infection, pneumonia, infections, tuberculosis, fungal infection, bacterial infection, viral infection, parasitic infection, ocular herpes simplex, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, cardiovascular disorders, decrease in bone mineral density, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, death"
162,FIRAZYR,adverse reactions,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
163,FIRAZYR,warnings and precautions,"laryngeal attacks, airway obstruction"
164,INVOKANA,adverse reactions,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increases in low-density lipoprotein (LDL-C), urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy (asthenia), pancreatitis, erythema, rash, pruritus, urticaria, angioedema, photosensitivity-related adverse reactions, volume depletion-related adverse reactions, postural dizziness, orthostatic hypotension, syncope, dehydration, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, vulvovaginal mycotic infection, vulvovaginal candidiasis, vulvovaginitis, candidal balanitis, balanoposthitis, phimosis, severe hypoglycemia, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), increases in hemoglobin, decreases in bone mineral density"
165,INVOKANA,warnings and precautions,"hypotension, renal impairment, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
166,VORAXAZE,adverse reactions,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, immunogenicity, anti-glucarpidase antibodies, neutralizing antibodies, death"
167,VORAXAZE,warnings and precautions,"serious allergic reactions, anaphylactic reactions, death"
168,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis, death"
169,NESINA,warnings and precautions,"acute pancreatitis, hypersensitivity reactions, anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic failure, death, hypoglycemia, severe and disabling arthralgia, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, liver enzyme elevations"
170,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, Liver transaminase elevation, Diarrhea, Cough, Influenza, Sinusitis, Back pain, Abdominal pain, Pain in extremity, Serum transaminase elevations, Basal cell carcinoma, Influenza, Sinusitis, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, Dizziness, Pneumonia, Eczema, Pruritus, Ischemic strokes, Hemorrhagic strokes, Peripheral arterial occlusive disease, Lymphoma."
171,GILENYA,warnings and precautions,"bradycardia, atrioventricular conduction, infections, progressive multifocal leukoencephalopathy (PML), macular edema, posterior reversible encephalopathy syndrome (PRES), decrease in pulmonary function tests (PFT), liver injury, blood pressure increase, symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, first-degree AV block, second-degree AV block, Mobitz Types I (Wenckebach), 2:1 AV blocks, third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus infection, reduction in heart rate, atrioventricular blocks, atypical MS relapse, forced expiratory volume over 1 second (FEV1) reduction, diffusion lung capacity for carbon monoxide (DLCO) reduction, dyspnea, elevation of liver transaminases, serum transaminase elevations, nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, dark urine, fetal harm, hypertension, immune system effects, lymphocyte count decrease, blurred vision, decreased visual acuity, headache, altered mental status, visual disturbances, seizure, ischemic stroke, cerebral hemorrhage, neurological sequelae, confusion, personality changes."
172,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, death"
173,HALAVEN,warnings and precautions,"neutropenia, severe neutropenia, ANC < 500/mm3, Grade 4 neutropenia, febrile neutropenia, alanine aminotransferase > 3 * ULN, aspartate aminotransferase > 3 * ULN, bilirubin > 1.5 * ULN, Grade 3 cytopenias, Grade 4 cytopenias, peripheral neuropathy, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, peripheral motor neuropathy, peripheral sensory neuropathy, embryo-fetal toxicity, teratogenicity, fetal harm, QT prolongation, congestive heart failure, bradyarrhythmias, hypokalemia, hypomagnesemia, congenital long QT syndrome"
174,INTELENCE,adverse reactions,"severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, Stevens-Johnson syndrome, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, rhabdomyolysis, toxic epidermal necrolysis, death."
175,INTELENCE,warnings and precautions,"Severe skin reactions, potentially life threatening skin reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 rashes, Grade 4 rashes, fever, general malaise, fatigue, muscle aches, joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, redistribution/accumulation of body fat, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, death."
176,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
177,AMYVID,warnings and precautions,"image interpretation errors, false negatives, radiation risk, cancer, unintentional radiation exposure"
178,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
179,ULESFIA,warnings and precautions,"gasping syndrome, eye irritation, contact dermatitis, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death"
180,OTEZLA,adverse reactions,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, insomnia, back pain, frequent bowel movements, depression, bronchitis, tooth abscess, folliculitis, sinus headache, psoriasis (rebound)"
181,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, drug interactions, loss of efficacy, depressed mood, suicidal ideation, suicidal behavior, attempted suicide, death"
182,ILARIS,adverse reactions,"infections, upper respiratory tract infections, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, tonsillitis, urinary tract infection, viral infection, hypersensitivity, decreased white blood cell counts, transient decreases in absolute neutrophil count, mild and transient decreases in platelet counts, elevations of transaminases, asymptomatic and mild elevations of serum bilirubin"
183,ILARIS,warnings and precautions,"serious infections, increased risk of serious infections, recurring infections, upper respiratory tract infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, tuberculosis, reactivation of latent tuberculosis, opportunistic infections, malignancies, hypersensitivity reactions, anaphylactic reactions, immunosuppression, ineffective vaccinations, macrophage activation syndrome (MAS), death"
184,NATAZIA,adverse reactions,"Serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, migraine, breast pain, discomfort, menstrual disorder, metrorrhagia, menorrhagia, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, acne, mood changes, depression, mood swings, altered mood, dysthymic disorder, crying, increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis"
185,NATAZIA,boxed warnings,serious cardiovascular events
186,NATAZIA,warnings and precautions,"thrombotic event, arterial thromboses, strokes, myocardial infarctions, venous thromboembolism (VTE), thromboembolic disease, cerebrovascular events, thrombotic strokes, hemorrhagic strokes, retinal vein thrombosis, jaundice, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, cholestasis, high blood pressure, hypertension, gallbladder disease, glucose tolerance decrease, dyslipidemia, adverse lipid changes, hypertriglyceridemia, pancreatitis, headaches, migraine, breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, intracyclic bleeding, depression, hereditary angioedema, chloasma, death"
187,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
188,DIFICID,warnings and precautions,"acute hypersensitivity reactions, angioedema, dyspnea, pruritus, rash, drug-resistant bacteria"
189,ONFI,adverse reactions,"somnolence, sedation, potentiation of sedation, central nervous system depressants, withdrawal symptoms, serious dermatological reactions, physical dependence, psychological dependence, suicidal behavior, ideation, constipation, pyrexia, lethargy, drooling, ataxia, aggression, fatigue, insomnia, vomiting, dysphagia, irritability, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, somnolence, sedation, lethargy, drooling, ataxia, psychomotor hyperactivity, dysarthria, aggression, insomnia, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial edema, lip edema, death"
190,ONFI,warnings and precautions,"somnolence, sedation, CNS depression, withdrawal symptoms, serious dermatological reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, physical dependence, psychological dependence, suicidal behavior, ideation, convulsions, psychosis, hallucinations, behavioral disorder, tremor, anxiety, dysphoria, insomnia, rash, depression, mood changes, suicidal thoughts, suicidal behavior, self-harm"
191,TECFIDERA,adverse reactions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, hepatic transaminases elevations, alanine aminotransferase elevation, eosinophilia"
192,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, difficulty breathing, urticaria, swelling of the throat, swelling of the tongue, Progressive multifocal leukoencephalopathy (PML), death, prolonged lymphopenia, lymphopenia, infections, serious infections, progressive weakness, clumsiness of limbs, disturbance of vision, changes in thinking, memory changes, orientation changes, confusion, personality changes, flushing, warmth, redness, itching, burning sensation, serious flushing symptoms."
193,DYSPORT,adverse reactions,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Facial Anatomy in the Treatment of Glabellar Lines, Pre-existing Neuromuscular Disorders, Human Albumin, Intradermal Immune Reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity, accommodation, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, muscle atrophy, dyspnea, blood glucose increase, ECG changes, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, numbness, discomfort, erythema, tenderness, tingling, itching, stinging, warmth, irritation, tightness, swelling, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, contusion, diarrhea, constipation, blood triglycerides increased, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, excessive granulation tissue, gait disturbance, hypertonia, sensation of heaviness."
194,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
195,DYSPORT,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, exacerbation of clinical effects, risk for transmission of Creutzfeldt-Jakob disease (CJD), asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, severe dysphagia, aspiration, weakness of neck muscles, respiratory failure, surgical alterations to facial anatomy, excessive weakness, atrophy in target muscles, marked facial asymmetry, inflammation at injection sites, excessive dermatochalasis, deep dermal scarring, thick sebaceous skin, eyelid ptosis, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junction disorders, severe dysphagia, respiratory compromise, transmission of viral diseases, immune reaction"
196,ZYTIGA,adverse reactions,"hypertension, hypokalemia, fluid retention, mineralocorticoid excess, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, joint discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, chest discomfort, cardiac failure, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, non-infectious pneumonitis, myopathy, rhabdomyolysis, death"
197,ZYTIGA,warnings and precautions,"mineralocorticoid excess, cardiovascular disease, LVEF < 50%, NYHA Class III heart failure, NYHA Class IV heart failure, NYHA Class II heart failure, hypertension, hypokalemia, fluid retention, adrenocortical insufficiency, hepatotoxicity, increases in liver enzymes, drug interruption, dose modification, discontinuation, liver function, grade 3 hypertension, grade 4 hypertension, grade 3 hypokalemia, grade 4 hypokalemia, grade 3 edema, grade 4 edema, heart failure, recent myocardial infarction, ventricular arrhythmia, adrenal insufficiency, interruption of daily steroids, concurrent infection, stress, grade 3 ALT increase, grade 4 ALT increase, grade 3 AST increase, grade 4 AST increase, liver test elevation, treatment discontinuation, serum transaminases increase, bilirubin levels increase, moderate hepatic impairment, AST rise above five times the ULN, ALT rise above five times the ULN, bilirubin rises above three times the ULN, AST greater than or equal to 20* ULN, ALT greater than or equal to 20* ULN, bilirubin greater than or equal to 10* ULN"
198,DUAVEE,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, all-cause mortality, serious adverse reactions, hot flush, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, death"
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, endometrial hyperplasia, abnormal genital bleeding, stroke, deep vein thrombosis (DVT), dementia, blood clots, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of asthma, diabetes, epilepsy, migraines, porphyria, lupus, liver problems, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain"
200,DUAVEE,warnings and precautions,"cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, thyroid function alteration, visual abnormalities, proptosis, diplopia, migraine, papilledema, elevated blood pressure, hypertriglyceridemia, pancreatitis, hepatic impairment, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, exacerbation of diabetes mellitus, exacerbation of epilepsy, exacerbation of migraine, exacerbation of porphyria, exacerbation of systemic lupus erythematosus, hepatic hemangiomas, impaired glucose tolerance"
201,SAPHRIS,adverse reactions,"Use in Elderly Patients with Dementia-Related Psychosis, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, Application site reactions, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, insomnia, hypertension, anxiety, depression, arthralgia, pain in extremity, headache, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, tachycardia, heart rate increased, glossodynia, muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, parkinsonism, suicidal ideation, anger, edema peripheral, dystonia, bradykinesia, dyskinesia, oromandibular dystonia, muscle contractions involuntary, muscle twitching, musculoskeletal stiffness, protrusion tongue, resting tremor, tremor, galactorrhea, dysmenorrhea, gynecomastia, anemia, thrombocytopenia, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, oral ulcers, blisters, peeling/sloughing, inflammation, choking, oropharyngeal muscular dysfunction, hypoesthesia, death"
202,SAPHRIS,boxed warnings,"increased mortality, death"
203,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, hyperglycemia, dyslipidemia, weight gain, hypersensitivity reactions, anaphylaxis, angioedema, Orthostatic Hypotension, Syncope, dizziness, tachycardia, bradycardia, Leukopenia, Neutropenia, Agranulocytosis, QT Prolongation, Seizures, Cognitive Impairment, Motor Impairment, Suicide, death, Dysphagia, hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, somnolence, body temperature regulation disruption, pyrexia, feeling hot, aspiration pneumonia, myocardial infarction, unstable heart disease, cardiac dysrhythmia, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure changes, diaphoresis, elevated creatine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, systemic infection, extrapyramidal signs and symptoms (EPS), central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system pathology, polydipsia, polyuria, polyphagia, weakness, ketoacidosis, hyperosmolar coma, LDL increase, HDL decrease, fasting triglycerides increase, weight z-score increase, swollen tongue, dyspnea, wheezing, rash, respiratory depression, central nervous system depression, fever, infection symptoms, torsade de pointes, bradycardia, hypokalemia, hypomagnesemia, congenital prolongation of the QT interval, hypothalamic GnRH suppression, reduced pituitary gonadotropin secretion, decreased bone density, prolactin-dependent breast cancers, operating hazardous machinery impairment, operating a motor vehicle impairment, esophageal dysmotility, aspiration."
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal thinning, scleral thinning, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritis, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis"
205,DUREZOL,warnings and precautions,"Intraocular pressure increase, glaucoma, damage to the optic nerve, defects in visual acuity, defects in fields of vision, posterior subcapsular cataract formation, delayed healing, increase in bleb formation, corneal or scleral thinning, corneal or scleral perforations, suppression of host response, secondary ocular infections, masking of infection, enhancement of existing infection, exacerbation of viral infections, prolongation of viral infections, herpes simplex, fungal infections of the cornea, persistent corneal ulceration, fungus invasion."
206,ZYDELIG,adverse reactions,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, sepsis, febrile neutropenia, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
207,ZYDELIG,boxed warnings,"hepatic toxicity, hepatotoxicity, severe diarrhea, diarrhea, colitis, pneumonitis, intestinal perforation, death"
208,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, death, ALT elevations, AST elevations, severe diarrhea, colitis, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, allergic reactions, Grade 3 neutropenia, Grade 4 neutropenia, teratogenic effects"
209,KALBITOR,adverse reactions,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, seroconversion, anti-ecallantide antibodies, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies, death"
210,KALBITOR,boxed warnings,"anaphylaxis, hypersensitivity reactions, hereditary angioedema"
211,KALBITOR,warnings and precautions,"anaphylaxis, hypersensitivity reactions, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
212,ADCETRIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, severe renal impairment, moderate or severe hepatic impairment, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, pneumonia, septic shock, supraventricular arrhythmia, urinary tract infection, Stevens-Johnson syndrome, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, toxic epidermal necrolysis, death"
213,ADCETRIS,boxed warnings,"progressive multifocal leukoencephalopathy (PML), JC virus infection, death"
214,ADCETRIS,warnings and precautions,"peripheral neuropathy, neuropathy, hypoesthesia, hyperesthesia, paresthesia, discomfort, burning sensation, neuropathic pain, weakness, anaphylaxis, infusion reactions, hematologic toxicities, neutropenia, thrombocytopenia, anemia, febrile neutropenia, fever, serious infections, opportunistic infections, pneumonia, bacteremia, sepsis, septic shock, death, tumor lysis syndrome, hepatotoxicity, hepatocellular injury, elevations of transaminases, elevations of bilirubin, progressive multifocal leukoencephalopathy (PML), noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), cough, dyspnea, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), embryo-fetal toxicity, fetal harm, decreased embryo viability, fetal malformations."
215,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
216,BESIVANCE,warnings and precautions,"Topical Ophthalmic Use Only, Growth of Resistant Organisms with Prolonged Use, Overgrowth of non-susceptible organisms, Super-infection, Avoidance of Contact Lenses, Signs or symptoms of bacterial conjunctivitis."
217,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation (possible pulmonary shunting)"
218,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbate heart failure, lipid intake restrictions, rebound hypertension"
219,XTANDI,adverse reactions,"seizure, asthenia, fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness, vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, sepsis, death, falls, fall-related injuries, hypertensive crisis"
220,XTANDI,warnings and precautions,"seizure, death"
221,BOSULIF,adverse reactions,"gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, platelet count low, absolute neutrophil count low, hemoglobin low, SGPT/ALT increased, SGOT/AST increased, lipase increased, phosphorus low, total bilirubin increased, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, abnormal hepatic function, liver injury, drug hypersensitivity, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption"
222,BOSULIF,warnings and precautions,"Gastrointestinal Toxicity, Diarrhea, Nausea, Vomiting, Abdominal Pain, Myelosuppression, Thrombocytopenia, Anemia, Neutropenia, Hepatic Toxicity, Drug induced liver injury, ALT elevation, AST elevation, Fluid Retention, Pericardial Effusion, Pleural Effusion, Pulmonary Edema, Peripheral Edema, Renal Toxicity, Decline in estimated glomerular filtration rate (eGFR), Kidney Failure, Embryofetal Toxicity, Fetal Harm"
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsillitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
224,CARBAGLU,warnings and precautions,"Hyperammonemia, injury to the brain, death, brain injury/damage, acute symptomatic hyperammonemia"
225,SIMPONI,adverse reactions,"serious infections, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis (TB), invasive fungal infections, malignancies, liver enzyme elevations, acute liver failure, autoimmune disorders, lupus-like syndrome, formation of autoantibodies, administration reactions, infusion reaction, rash, immunogenicity, antibodies to SIMPONI ARIA, neutralizing antibodies, upper respiratory tract infection, nasopharyngitis, pharyngitis, laryngitis, rhinitis, viral infections, influenza, herpes, bacterial infections, bronchitis, vascular disorders, hypertension, skin and subcutaneous disorders, pyrexia, blood and lymphatic disorders, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, investigations, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, nervous system disorders, dizziness, paresthesia, gastrointestinal disorders, constipation, neoplasm benign and malignant, melanoma, immune system disorders, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, respiratory, thoracic and mediastinal disorders, interstitial lung disease, skin and subcutaneous tissue disorders, skin exfoliation, bullous skin reactions"
226,SIMPONI,boxed warnings,"serious infections, hospitalization, death, tuberculosis (TB), bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, sepsis, lymphoma, malignancies, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria"
227,SIMPONI,warnings and precautions,"serious infections, invasive fungal infections, Hepatitis B reactivation, malignancies, lymphoma, heart failure, demyelinating disease, hypersensitivity reactions, anaphylaxis, opportunistic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, sepsis, reactivation of tuberculosis, new tuberculosis infections, Hepatitis B Virus Reactivation, Malignancies in Pediatric Patients, Hodgkin's lymphoma, non-Hodgkin's lymphoma, Malignancies in Adult Patients, acute leukemia, chronic leukemia, hepatosplenic T-cell lymphoma (HSTCL), Melanoma, Merkel cell carcinoma, Congestive Heart Failure, worsening congestive heart failure, new onset CHF, Demyelinating Disorders, central nervous system demyelinating disorders, multiple sclerosis (MS), peripheral demyelinating disorders, Guillain-Barre syndrome, central demyelination, optic neuritis, peripheral demyelinating polyneuropathy, Hematologic Cytopenias, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia, Vaccinations/Therapeutic Infectious Agents, Live Vaccines, disseminated infections, Therapeutic Infectious Agents, death"
228,BENLYSTA,adverse reactions,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions, Anaphylaxis, Infusion Reactions, Depression, Nausea, Diarrhea, Pyrexia, Nasopharyngitis, Bronchitis, Insomnia, Pain in extremity, Migraine, Pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, Fatal anaphylaxis, death"
229,BENLYSTA,warnings and precautions,"mortality, deaths, serious infections, fatal infections, chronic infections, Progressive Multifocal Leukoencephalopathy (PML), neurological signs and symptoms, Hypersensitivity Reactions, Anaphylaxis, fatal reactions, Depression, suicidality, worsening depression, suicidal thoughts, mood changes, Immunization, upper respiratory tract infection, urinary tract infection, nasopharyngitis, sinusitis, bronchitis, influenza, pneumonia, cellulitis, Malignancy, non-melanoma skin cancers, rash, nausea, fatigue, myalgia, headache, facial edema, hypersensitivity, hypotension, angioedema, urticaria, pruritus, dyspnea, Infusion Reactions, bradycardia, skin reactions, insomnia, anxiety, psychiatric events, serious psychiatric events, serious depression, suicides, death"
230,TOVIAZ,adverse reactions,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, angina, chest pain, gastroenteritis, QT prolongation on ECG, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation"
231,TOVIAZ,warnings and precautions,"Angioedema, urinary retention, severe constipation, narrow-angle glaucoma, somnolence, headache, dizziness, life-threatening (death), hypopharynx involvement, larynx involvement, patent airway obstruction, anticholinergic central nervous system effects, hepatic impairment, renal impairment, myasthenia gravis"
232,ENTEREG,adverse reactions,dyspepsia
233,ENTEREG,boxed warnings,"myocardial infarction, death"
234,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea, vomiting, diarrhea, serious adverse reactions, death"
235,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, death"
236,VIZAMYL,warnings and precautions,"hypersensitivity reactions, flushing, dyspnea, image interpretation errors, false positives, radiation risk, cancer, unintentional radiation exposure"
237,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state"
238,AMPYRA,warnings and precautions,"seizures, anaphylaxis, renal impairment, severe allergic reactions, respiratory compromise, urticaria, angioedema, urinary tract infections"
239,ADCETRIS,all-concat,"peripheral neuropathy, peripheral sensory neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, embryo-fetal toxicity, neutropenia, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, abdominal pain, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), death"
240,ADREVIEW,all-concat,"hypersensitivity reactions, dizziness, rash, pruritus, flushing, headache, injection site hemorrhage, hematoma, bruising, benzyl alcohol toxicity, hypotension, metabolic acidosis, kernicterus, increased radiation exposure, thyroid neoplasia, hypertension, death"
241,AFINITOR,all-concat,"non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, anemia, leukopenia, thrombocytopenia, lymphopenia, increased aspartate transaminase (AST), increased alanine transaminase (ALT), hypertriglyceridemia, lymphopenia, hyperglycemia, anemia, decreased potassium, increased AST, increased ALT, thrombocytopenia, death, vomiting, constipation, dry mouth, edema peripheral, pyrexia, infections, weight decreased, arthralgia, back pain, pain in extremity, dysgeusia, insomnia, epistaxis, pruritus, alopecia, hot flush, hemoglobin decreased, WBC decreased, platelets decreased, lymphocytes decreased, neutrophils decreased, glucose increased, cholesterol increased, triglycerides increased, albumin decreased, creatinine increased, abdominal pain, diabetes mellitus, muscle spasms, headache/migraine, dizziness, cough/productive cough, dyspnea/dyspnea exertional, oropharyngeal pain, nail disorders, pruritus/pruritus generalized, dry skin/xeroderma, hypertension, hemoglobin decreased, lymphocytes decreased, platelets decreased, WBC decreased, neutrophils decreased, alkaline phosphatase increased, glucose (fasting) increased, cholesterol increased, bicarbonate decreased, aspartate transaminase (AST) increased, alanine transaminase (ALT) increased, phosphate decreased, triglycerides increased, calcium decreased, potassium decreased, sodium decreased, albumin decreased, bilirubin increased, potassium increased, asthenia, edema peripheral, mucosal inflammation, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome, nail disorder, erythema, onychoclasis, skin lesion, acneiform dermatitis, angioedema, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, tachycardia, congestive cardiac failure, jaw pain, hemorrhage, elevated partial thromboplastin time, neutropenia, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, respiratory tract infection, gastroenteritis, aggression, agitation, amenorrhea, elevated partial thromboplastin time, neutropenia, hypercholesterolemia, hypophosphatemia, peripheral edema, upper respiratory tract infection, arthralgia, cough, acne, menorrhagia, menstrual irregularities, vaginal hemorrhage, epistaxis, decreased appetite, otitis media, depression, abnormal taste, increased blood luteinizing hormone (LH) levels, increased blood follicle stimulating hormone (FSH) levels, hypersensitivity, ovarian cyst, pneumonitis, angioedema, cellulitis, hyperglycemia, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, pleural effusion, pharyngolaryngeal pain, rhinorrhea, palmar-plantar erythrodysesthesia syndrome, erythema, skin lesion, acneiform dermatitis, insomnia, dizziness, paresthesia, eyelid edema, conjunctivitis, hypertension, deep vein thrombosis, renal failure, hemorrhage, hypoxia, pleural effusion, cough, dyspnea, opportunistic infections, pneumonia, mycobacterial infections, invasive fungal infections, aspergillosis, candidiasis, pneumocystis jiroveci pneumonia (PJP), viral infections, hepatitis B virus reactivation, sepsis, respiratory failure, hepatic failure, pulmonary embolism, myocardial infarction, congestive heart failure, sudden death, thrombotic events, pulmonary embolus, thrombosis, abdominal pain, dry mouth, hemorrhoids, dysphagia, impaired wound healing, chest pain, chills, abdominal pain, diarrhea, nausea, vomiting, constipation, dry mouth, peripheral edema, fever, asthenia, nasopharyngitis, rhinitis, upper respiratory infection, urinary tract infection, weight decreased, diabetes mellitus, arthralgia, back pain, pain in extremity, muscle spasms, headache/migraine, dysgeusia, dizziness, insomnia, cough, epistaxis, dyspnea, pneumonitis, oropharyngeal pain, rash, nail disorders, pruritus, dry skin, hypertension, alkaline phosphatase increased, bicarbonate decreased, phosphate decreased, calcium decreased, potassium decreased, sodium decreased, bilirubin increased, potassium increased, stomatitis, vomiting, diarrhea, constipation, peripheral edema, upper respiratory tract infection, arthralgia, cough, acne, amenorrhea, menorrhagia, menstrual irregularities, vaginal hemorrhage, epistaxis, decreased appetite, otitis media, depression, abnormal taste, increased blood LH levels, increased blood FSH levels, hypersensitivity, ovarian cyst, pneumonitis, angioedema, respiratory tract infection, gastroenteritis, pyrexia, fatigue, aggression, agitation, rash, acne, dysmenorrhea, metrorrhagia, unspecified menstrual irregularity, nausea, pain in extremity, insomnia, pneumonia, hypersensitivity, increased blood LH levels, pneumonitis, elevated partial thromboplastin time, anemia, hypercholesterolemia, elevated AST, hypertriglyceridemia, elevated ALT, hypophosphatemia, hyperglycemia, elevated creatinine."
242,AMPYRA,all-concat,"seizures, anaphylaxis, urinary tract infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state, death"
243,AMYVID,all-concat,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing, death"
244,APTIOM,all-concat,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, rash, dysarthria, ear and labyrinth disorders, eye disorders, visual impairment, gastrointestinal disorders, diarrhea, constipation, abdominal pain, gastritis, general disorders and administration site conditions, gait disturbance, peripheral edema, infections and infestations, urinary tract infections, injury, poisoning and procedural complications, fall, metabolism and nutrition disorders, nervous system disorders, balance disorder, memory impairment, nystagmus, psychiatric disorders, depression, insomnia, respiratory, thoracic and mediastinal disorders, cough, skin and subcutaneous tissue disorders, vascular disorders, hypertension, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase, cognitive dysfunction, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, impaired vision, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, fever, lymphadenopathy, laryngeal edema, seizures, severe nausea/vomiting, severe gait instability, injury, hypochloremia, fatigue-related adverse reactions, asthenia, malaise, hypersomnia, sedation, lethargy, visual changes, hazardous activities, withdrawal of AEDs, elevated transaminases, elevated bilirubin, decreased serum T3 and T4."
245,ARCAPTA,all-concat,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, death"
246,BELEODAQ,all-concat,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, hepatic failure, ventricular fibrillation, febrile neutropenia, leukopenia (neutropenia and lymphopenia), serious infections (e.g., pneumonia and sepsis), liver function test abnormalities, fetal harm, teratogenicity, embryo-fetal lethality, death"
247,BENLYSTA,all-concat,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions, Anaphylaxis, Infusion Reactions, Depression, Nausea, Diarrhea, Pyrexia, Nasopharyngitis, Bronchitis, Insomnia, Pain in extremity, Migraine, Pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, Fatal anaphylaxis, Progressive Multifocal Leukoencephalopathy (PML), Upper respiratory tract infection, Urinary tract infection, Sinusitis, Influenza, Pneumonia, Cellulitis, Lupus nephritis, Erythematous rash, Pruritus, Eyelid edema, Headache, Dyspnea, Cardiovascular disease, Suicide, Myalgia, Facial edema, Bradycardia, Urticaria, Hypotension, Skin reactions, Anxiety, death"
248,BEPREVE,all-concat,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
249,BESIVANCE,all-concat,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache, overgrowth of non-susceptible organisms, super-infection, fungal infection"
250,BLINCYTO,all-concat,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, Anemia, Thrombocytopenia, Leukopenia, Diarrhea, Abdominal pain, Vomiting, Fatigue, Chills, Chest pain, Cytokine release syndrome, Other pathogen infections, Bacterial infections, Fungal infections, Viral infections, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased weight, Hypomagnesemia, Hyperglycemia, Decreased appetite, Hypophosphatemia, Back pain, Pain in extremity, Bone pain, Arthralgia, Dizziness, Insomnia, Cough, Dyspnea, Hypotension, Hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm, death."
251,BOSULIF,all-concat,"gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, platelet count low, absolute neutrophil count low, hemoglobin low, SGPT/ALT increased, SGOT/AST increased, lipase increased, phosphorus low, total bilirubin increased, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, chest discomfort, pain, hepatotoxicity, toxic hepatitis, cytolytic hepatitis, liver disorder, liver injury, drug hypersensitivity, pneumonia, bronchopneumonia, lobar pneumonia, primary atypical pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption, embryofetal toxicity, death"
252,BREO,all-concat,"asthma-related death, death, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, bronchitis, sinusitis, cough, oropharyngeal pain, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, pharyngitis, pyrexia, arthralgia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, paradoxical bronchospasm, hypokalemia, hyperglycemia"
253,CARBAGLU,all-concat,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash, hyperammonemia, brain injury, death"
254,CERDELGA,all-concat,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, ECG changes, cardiac arrhythmias, PR interval prolongation, QTc interval prolongation, QRS interval prolongation"
255,CHOLINE,all-concat,"mild injection site reaction, imaging errors, allergic reactions, anaphylaxis, radiation risk, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, cancer risk"
256,CIMZIA,all-concat,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, active tuberculosis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial sepsis, Legionella, Listeria, hepatitis B virus reactivation, demyelinating disease, cytopenias, lupus-like syndrome, immunogenicity, hypersensitivity reactions, angioedema, dermatitis allergic, dizziness (postural), dyspnea, hot flush, hypotension, malaise, serum sickness, syncope, death"
257,CLEVIPREX,all-concat,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, serious adverse events, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation, possible pulmonary shunting, negative inotropic effects, exacerbate heart failure, rebound hypertension, death"
258,COARTEM,all-concat,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, aspartate aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption), QT prolongation, death"
259,COMETRIQ,all-concat,"perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome (PPES), proteinuria, reversible posterior leukoencephalopathy syndrome (RPLS), diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, cardiac arrest, respiratory failure, unspecified death, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone (TSH), dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, dysgeusia, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hemoptysis, gastrointestinal hemorrhage, myocardial infarction, cerebral infarction, arterial thromboembolism, venous thromboembolism, dehiscence, hypertensive crisis, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, nephrotic syndrome, seizures, visual disturbances, confusion, altered mental function, death."
260,DALVANCE,all-concat,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, death (implied by fatal colitis in CDAD)"
261,DATSCAN,all-concat,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, hypersensitivity reactions, rash, pruritis, skin erythema, anaphylactic reactions, thyroid neoplasia"
262,DIFICID,all-concat,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema, death"
263,DOTAREM,all-concat,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis, death"
264,DUAVEE,all-concat,"cardiovascular disorders, malignant neoplasms, gallbladder disease, hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, endometrial cancer, stroke, deep vein thrombosis (DVT), probable dementia, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems, breast cancer, ovarian cancer, blood clots, heart attack, cancer of the lining of the uterus, dementia, visual abnormalities, retinal vascular thrombosis, elevated blood pressure, pancreatitis, hepatic impairment, cholestatic jaundice, hypothyroidism, hypocalcemia, hereditary angioedema, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, hot flush, death"
265,DUREZOL,all-concat,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, perforation of the globe, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritus, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis, glaucoma, defects in visual fields, delayed healing, bleb formation, bacterial infections, viral infections, fungal infections"
266,DYSPORT,all-concat,"distant spread of toxin effect, lack of interchangeability between botulinum toxin products, spread of effects from toxin, dysphagia, breathing difficulties, facial anatomy in the treatment of glabellar lines, pre-existing neuromuscular disorders, human albumin, intradermal immune reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity and accommodation, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, breathing difficulty, dyspnea, muscle atrophy, blood glucose increase, electrocardiographic findings, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, numbness, erythema, tenderness, tingling, itching, stinging, warmth, irritation, tightness, swelling, facial paresis, hypoesthesia, excessive granulation tissue, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, erythema, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, hypertension, psychiatric disorders, cough, vascular disorders, immunogenicity, antibody formation, binding antibodies, neutralizing antibodies, death"
267,EDARBI,all-concat,"diarrhea, hypotension, orthostatic hypotension, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, nausea, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, rash, pruritus, angioedema, fetal toxicity, oliguria, azotemia, acute renal failure, death"
268,ELIQUIS,all-concat,"thrombotic events, bleeding, spinal/epidural anesthesia or puncture, hemorrhagic stroke, gastrointestinal (GI) bleed, fatal bleeding, intracranial bleed, non-intracranial bleed, hypersensitivity reactions, skin rash, anaphylactic reactions, allergic edema, syncope, hemorrhagic anemia, gastrointestinal hemorrhage, hematemesis, melena, anal hemorrhage, hematochezia, hemorrhoidal hemorrhage, wound hemorrhage, postprocedural hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma, nausea, anemia, postoperative anemia, hemorrhagic anemia, contusion, hemorrhage, hematoma, vaginal hemorrhage, urethral hemorrhage, postprocedural hematoma, wound hemorrhage, vessel puncture site hematoma, catheter site hemorrhage, transaminases increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, platelet count decreases, hypotension, procedural hypotension, respiratory disorders, epistaxis, thoracic disorders, mediastinal disorders, hepatobiliary disorders, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, renal disorders, hematuria, urinary disorders, injury, poisoning, procedural complications, wound secretion, incision-site hemorrhage, incision-site hematoma, operative hemorrhage, gingival bleeding, hemoptysis, death"
269,ENTEREG,all-concat,"dyspepsia, myocardial infarction, abdominal pain, nausea, vomiting, diarrhea, serious adverse reactions, death"
270,EOVIST,all-concat,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, Nausea, Headache, Feeling hot, Dizziness, Back pain, Vomiting, Blood pressure increased, Injection site reactions, Dysgeusia, Paresthesia, Flushing, Parosmia, Pruritus, Rash, Respiratory disorders, Fatigue, Chest pain, Vertigo, Dry mouth, Chills, Feeling abnormal, Tremor, Akathisia, Bundle branch block, Palpitation, Oral discomfort, Salivary hypersecretion, Maculopapular rash, Hyperhidrosis, Discomfort, Malaise, Elevation of serum iron values, Elevation of serum bilirubin, Anaphylactic shock, Hypotension, Pharyngolaryngeal edema, Urticaria, Face edema, Rhinitis, Conjunctivitis, Abdominal pain, Hypoesthesia, Sneezing, Cough, Pallor, Tachycardia, Restlessness, Acute kidney injury, Myocyte necrosis, Inflammation, Serum iron determination interference, Impaired EOVIST imaging performance, death"
271,ERWINAZE,all-concat,"hypersensitivity reactions, anaphylaxis, pancreatitis, severe pancreatitis, hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, coagulopathy, hyperbilirubinemia, hyperlipidemia, ketoacidosis, CNS events, cerebral venous thrombosis, allergic reactions, thrombotic events, hemorrhagic events, hepatobiliary disorders, pancreatic disorders, death"
272,EYLEA,all-concat,"endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal tear, retinal detachment, death"
273,FANAPT,all-concat,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, weight increased, vision blurred, nausea, dry mouth, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, dizziness, somnolence, extrapyramidal disorder, tremor, lethargy, ejaculation failure, nasal congestion, dyspnea, rash, orthostatic hypotension, hypotension, death, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, restlessness, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, cerebrovascular accidents, transient ischemic attacks, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome (NMS), tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, weight gain, seizures, leukopenia, neutropenia, agranulocytosis, suicide, priapism, cognitive impairment, motor impairment, hyperprolactinemia, body temperature regulation disruption, dysphagia."
274,FARXIGA,all-concat,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increases in low-density lipoprotein cholesterol (LDL-C), bladder cancer, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, volume depletion, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, increase in LDL cholesterol"
275,FERRIPROX,all-concat,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension, death"
276,FIRAZYR,all-concat,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
277,FULYZAQ,all-concat,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
278,GADAVIST,all-concat,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, death"
279,GILENYA,all-concat,"bradyarrhythmia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, nausea, asthenia, alopecia, actinic keratosis, blood triglycerides increased, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphomas, bradycardia, hypotension, palpitations, chest pain, second-degree AV blocks, Mobitz Types I, 2:1 AV blocks, third-degree AV block, AV block with junctional escape, syncope, transient asystole, death, herpetic infections, herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, cryptococcal infections, cryptococcal meningitis, varicella zoster virus, progressive weakness, disturbance of vision, changes in thinking, memory, confusion, personality changes, forced expiratory volume decrease, diffusion lung capacity for carbon monoxide decrease, elevation of liver enzymes, nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, dark urine, fetal harm, blood pressure increase, immune system effects"
280,GILOTRIF,all-concat,"diarrhea, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, bullous skin disorders, exfoliative skin disorders, interstitial lung disease (ILD), hepatic toxicity, keratitis, embryofetal toxicity, serious adverse reactions, pulmonary toxicity, ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, gastrointestinal disorders, cheilitis, skin and subcutaneous tissue disorders, infections and infestations, cystitis, metabolism and nutrition disorders, respiratory, thoracic and mediastinal disorders, epistaxis, rhinorrhea, investigations, weight decreased, general disorders and administration site conditions, pyrexia, eye disorders, conjunctivitis, laboratory abnormalities, alanine aminotransferase increased, hypokalemia, aspartate aminotransferase increased, pancreatitis, dehydration, renal failure, bullous, blistering, exfoliating lesions, lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, liver test abnormalities, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, abortions, death."
281,GRANIX,all-concat,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Use in Patients with Sickle Cell Disease, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, anaphylaxis, Sickle cell crisis, hypotension, hypoalbuminemia, edema, hemoconcentration, death"
282,HALAVEN,all-concat,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, death"
283,HORIZANT,all-concat,"somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase, driving impairment, suicidal thoughts or behaviors, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, withdrawal seizure, pancreatic acinar cell adenoma, pancreatic acinar cell carcinoma, insomnia, asthenia, confusional state, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, withdrawal seizure, tumorigenic potential"
284,ILARIS,all-concat,"infections, upper respiratory tract infections, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, tonsillitis, urinary tract infection, viral infection, abdominal pain (upper), rhinitis, tonsillitis, sinusitis, urinary tract infection, viral infection, hypersensitivity, immunogenicity, decreased white blood cells, neutrophils, platelets, elevations of transaminases, asymptomatic and mild elevations of serum bilirubin, immunosuppression, malignancies, anaphylactic reactions, live vaccine administration risks, macrophage activation syndrome (MAS), tuberculosis reactivation, latent tuberculosis infection."
285,IMBRUVICA,all-concat,"hemorrhage, bleeding, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, embryo-fetal toxicity, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, renal failure, creatinine increased, stomatitis, dyspepsia, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, laceration, anxiety, insomnia, hypertension, hyperuricemia, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, uric acid levels elevated, hypersensitivity reactions, anaphylactic shock, death, urticaria, angioedema, subdural hematoma, hematuria, post procedural hemorrhage, bruising, petechiae, progressive multifocal leukoencephalopathy (PML), fever, non-skin carcinomas, non-melanoma skin cancer, malformations in animals, reduced fetal weights, arthropathy, gastroesophageal reflux disease, pruritus, sinusitis, oropharyngeal pain, peripheral neuropathy, second malignancies, contusion, vision blurred, skin cancer."
286,INLYTA,all-concat,"hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS, proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hypertensive crisis, cerebrovascular accident, myocardial infarction, retinal artery occlusion, gastric hemorrhage, death"
287,INTELENCE,all-concat,"severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS, hepatic failure, rhabdomyolysis, death"
288,INVOKANA,all-concat,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increases in low-density lipoprotein (LDL-C), female genital mycotic infections, urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy, asthenia, pancreatitis, erythema, rash, pruritus, urticaria, angioedema, photosensitivity reaction, polymorphic light eruption, sunburn, volume depletion-related adverse reactions, hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, vulvovaginal mycotic infection, vulvovaginal candidiasis, vulvovaginitis, candidal balanitis, balanoposthitis, phimosis, severe hypoglycemia, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in non-high-density lipoprotein cholesterol (non-HDL-C), increases in hemoglobin, decreases in bone mineral density"
289,JARDIANCE,all-concat,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased low-density lipoprotein cholesterol (LDL-C), urinary tract infection, asymptomatic bacteriuria, cystitis, vulvovaginal mycotic infection, vaginal infection, vulvitis, vulvovaginal candidiasis, genital infection, genital candidiasis, genital infection fungal, genitourinary tract infection, vulvovaginitis, cervicitis, urogenital infection fungal, vaginitis bacterial, polyuria, pollakiuria, nocturia, dyslipidemia, arthralgia, balanoposthitis, balanitis, scrotal abscess, penile infection, nausea, thirst, polydipsia, volume depletion, blood pressure decreased, blood pressure systolic decreased, dehydration, hypovolemia, orthostatic hypotension, syncope, increased urination, serum creatinine increase, eGFR decrease, hematocrit increase, phimosis"
290,JEVTANA,all-concat,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, Arrhythmia, Dyspepsia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, sepsis, septic shock, Gastritis, intestinal obstruction, generalized rash/erythema, bronchospasm, neutropenic infections, neutropenic enterocolitis, gastrointestinal hemorrhage, gastrointestinal perforation, ileus, enterocolitis, death."
291,JUBLIA,all-concat,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
292,KALBITOR,all-concat,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, chest discomfort, flushing, pharyngeal edema, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash, death"
293,KALYDECO,all-concat,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, increased hepatic enzymes, hypoglycemia, rhinitis, aspartate aminotransferase increased, bacteria in sputum, blood glucose increased, arthralgia, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, cataracts"
294,KYPROLIS,all-concat,"cardiac toxicities, cardiac failure, myocardial infarction, myocardial ischemia, cardiac arrest, congestive heart failure, pulmonary edema, decreased ejection fraction, restrictive cardiomyopathy, acute renal failure, renal insufficiency, renal impairment, tumor lysis syndrome, pulmonary toxicity, acute respiratory distress syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pneumonitis, interstitial lung disease, pulmonary hypertension, dyspnea, dyspnea exertional, hypertension, hypertensive crisis, hypertensive emergency, venous thrombosis, thromboprophylaxis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, PRES, embryo-fetal toxicity, febrile neutropenia, lymphopenia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, dysphonia, epistaxis, oropharyngeal pain, pulmonary embolism, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, death."
295,LUMIZYME,all-concat,"hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, serious adverse reactions, angioedema, throat tightness, chest pain/discomfort, supraventricular tachycardia, local swelling, diarrhea, pruritus, delayed-onset reactions, hyperhidrosis, paresthesia, edema, peripheral, rash papular, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, immune-mediated reactions, flu-like illness, chills, arthralgia, pain, immune complex deposition, acute exacerbation of cardiac or respiratory compromise, cardiac arrhythmia, sudden cardiac death, severe cardiac and skeletal muscle weakness, ventricular arrhythmias, bradycardia, cardiac hypertrophy, fluid overload, death"
296,MULTAQ,all-concat,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, early increases in creatinine, QTc prolonged, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis, stroke, hepatocellular liver injury, acute liver failure, dyspnea, non-productive cough, marked increase in serum creatinine, pre-renal azotemia, acute renal failure, death"
297,NATAZIA,all-concat,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, menstrual disorders, vomiting, acne, mood changes, increased weight, metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying, breast pain, discomfort, tenderness, abnormal withdrawal bleeding, uterine hemorrhage, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis, high blood pressure, uncontrolled hypertension, carbohydrate and lipid metabolic effects, uncontrolled dyslipidemia, cerebrovascular events, thrombotic strokes, hemorrhagic strokes, retinal vein thrombosis, carcinoma of the breasts, cervical cancer, intraepithelial neoplasia, hepatocellular carcinoma, pancreatitis, breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, intracyclic bleeding, birth defects, teratogenic effect, depression recurrence, laboratory test interference, hereditary angioedema, exacerbation of angioedema symptoms, death (due to rupture of hepatic adenomas causing intra-abdominal hemorrhage)"
298,NESINA,all-concat,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, death, severe and disabling arthralgia"
299,NEURACEQ,all-concat,"erythema, irritation, pain, image interpretation errors, false positives, radiation exposure, cancer, death"
300,NORTHERA,all-concat,"supine hypertension, hyperpyrexia, confusion, exacerbate existing ischemic heart disease, arrhythmias, congestive heart failure, headache, dizziness, nausea, hypertension, fatigue, falls, urinary tract infections, syncope, allergic reactions, death"
301,NULOJIX,all-concat,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, post-transplant lymphoproliferative disorder, other malignancies, progressive multifocal leukoencephalopathy, bacterial infections, mycobacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, herpes infections, CNS infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion reactions, hypotension, hypertension, proteinuria, immunogenicity, new-onset diabetes after transplantation, NODAT, dyslipidemia, infections and infestations, upper respiratory infection, nasopharyngitis, influenza, bronchitis, gastrointestinal disorders, abdominal pain, abdominal pain upper, metabolism and nutrition disorders, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, procedural complications, general disorders, blood and lymphatic system disorders, renal and urinary disorders, hematuria, proteinuria, dysuria, renal tubular necrosis, vascular disorders, hematoma, lymphocele, respiratory disorders, dyspnea, musculoskeletal disorders, arthralgia, back pain, nervous system disorders, dizziness, tremor, skin disorders, acne, psychiatric disorders, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, musculoskeletal pain, alopecia, hyperhidrosis, cardiac disorders, atrial fibrillation, death."
302,ONFI,all-concat,"somnolence, sedation, potentiation of sedation, withdrawal symptoms, serious dermatological reactions, physical dependence, psychological dependence, suicidal behavior, suicidal ideation, constipation, pyrexia, lethargy, drooling, vomiting, dysphagia, irritability, fatigue, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, ataxia, aggression, insomnia, psychomotor hyperactivity, dysarthria, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial edema, lip edema, Stevens-Johnson syndrome, toxic epidermal necrolysis, convulsions, psychosis, behavioral disorder, tremor, dysphoria, insomnia, status epilepticus"
303,OTEZLA,all-concat,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, depression, suicidal thoughts, suicidal behavior, back pain, insomnia, frequent bowel movements, bronchitis, tooth abscess, folliculitis, sinus headache, death"
304,PICATO,all-concat,"local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn, eyelid ptosis, anaphylaxis"
305,POTIGA,all-concat,"retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy, hydronephrosis"
306,PRADAXA,all-concat,"bleeding, gastritis-like symptoms, gastrointestinal events, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, diarrhea, major bleeding, decrease in hemoglobin, transfusion of packed red blood cells, bleeding at a critical site, fatal outcome, death, intracranial hemorrhage, intracerebral hemorrhage, hemorrhagic stroke, subarachnoid bleed, subdural bleed, gastrointestinal bleed, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, symptomatic bleeding, critical area or organ bleeding, intraocular bleed, intraspinal bleed, intramuscular with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, angioedema, thrombocytopenia, esophageal ulcer, spinal/epidural hematoma, thrombotic events, thromboembolic events, valve thrombosis, transient ischemic attack, myocardial infarction, post-operative pericardial effusions, mechanical prosthetic valves, bioprosthetic heart valves, P-gp inducers and inhibitors influence, renal impairment"
307,PRISTIQ,all-concat,"hypersensitivity, suicidal thoughts and behaviors, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, male sexual function disorders, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, lipid abnormalities, proteinuria, orthostatic hypotension, Stevens-Johnson syndrome, clinical worsening, suicide risk, hypertension, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, death"
308,PROLIA,all-concat,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, pancreatitis, death, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, new malignancies, cataracts, drug-related hypersensitivity reactions, anaphylaxis, facial swelling, erythema, severe symptomatic hypocalcemia, severe bone, joint, muscle pain, marked elevation in serum PTH, immunogenicity, hypersensitivity reactions including anaphylactic reactions, suppression of bone turnover, endocarditis, erysipelas, cellulitis, opportunistic infections, epidermal and dermal adverse events, dermatitis, eczema, rashes, severe musculoskeletal pain, bone remodeling suppression, osteonecrosis of the jaw (ONJ), atypical femoral fractures, severe infection, severe bone, joint, and muscle pain, delayed fracture healing"
309,PROMACTA,all-concat,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, abdominal pain, toothache, Vitamin D deficiency, febrile neutropenia, pain in extremity, dyspnea, dizziness, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, portal vein thromboses, Thrombotic microangiopathy with acute renal failure, ascites, encephalopathy, indirect hyperbilirubinemia, liver injury, hepatic decompensation, portal venous system thrombosis, venous events, arterial events, Factor V Leiden, ATIII deficiency, antiphospholipid syndrome, chronic liver disease, portal vein thrombosis (PVT), abdominal pain, nausea, vomiting, diarrhea, death"
310,QUTENZA,all-concat,"application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor, transient increases in blood pressure, aerosolization of capsaicin, eye and mucous membrane exposure, unintended skin exposure, application associated pain"
311,SAPHRIS,all-concat,"dementia-related psychosis, death, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, hyperglycemia, dyslipidemia, weight gain, Hypersensitivity Reactions, anaphylaxis, angioedema, Application site reactions, oral ulcers, blisters, peeling/sloughing, inflammation, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Cognitive and Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Cerebrovascular Adverse Events, stroke, transient ischemic attack, choking, oropharyngeal muscular dysfunction, hypoesthesia, increased mortality, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, tachycardia, bradycardia, myocardial infarction, ischemic heart disease, heart failure, conduction abnormalities, cerebrovascular disease, dehydration, hypovolemia, antihypertensive medications, hypotension, hypokalemia, hypomagnesemia, congenital prolongation of the QT interval, diabetes mellitus, ketoacidosis, hyperosmolar coma, polydipsia, polyuria, polyphagia, weakness, fasting glucose testing, hyperglycemia-related adverse events, glucose abnormalities, fasting blood glucose testing, hyperglycemia, glucose control, blood glucose testing, undesirable alterations in lipids, cardiovascular/cerebrovascular risk, lipid changes, total cholesterol, LDL, HDL, fasting triglycerides, fasting glucose, fasting cholesterol, fasting LDL, fasting HDL, fasting triglycerides, body weight, weight gain criterion, weight z-score, prolactin levels, hypothalamic GnRH, gonadal steroidogenesis, galactorrhea, amenorrhea, gynecomastia, impotence, bone density, breast cancer, seizure threshold, mental alertness, hazardous machinery, motor vehicle, core body temperature, pyrexia, feeling hot, esophageal dysmotility, aspiration, aspiration pneumonia, Alzheimer's dementia, myocardial infarction, unstable heart disease, cardiac patients, orthostatic hypotension"
312,SIMPONI,all-concat,"serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis (TB), invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, lupus-like syndrome, ANA-positive, anti-dsDNA antibodies, administration reactions, infusion reaction, immunogenicity, antibodies to SIMPONI ARIA, neutralizing antibodies, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, pyrexia, leukopenia, melanoma, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, interstitial lung disease, skin exfoliation, bullous skin reactions, hepatitis B reactivation, heart failure, demyelinating disease, exacerbation of demyelinating disease, pancytopenia, aplastic anemia, thrombocytopenia, live vaccine reaction, therapeutic infectious agents, anaphylactic or other serious allergic reaction, death"
313,SIRTURO,all-concat,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, Transaminases Increased, Rash, Blood Amylase Increased, aminotransferase elevations, Clinically significant ventricular arrhythmia, QTcF interval greater than 500 ms, fatigue, jaundice, dark urine, liver tenderness, hepatomegaly, total bilirubin elevation greater than two times the upper limit of normal, aminotransferase elevations greater than eight times the upper limit of normal, aminotransferase elevations greater than five times the upper limit of normal, death"
314,STENDRA,all-concat,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, dizziness, gastroenteritis viral, color vision changes, Non-arteritic anterior ischemic optic neuropathy (NAION), sudden loss of vision, priapism, sudden decrease or loss of hearing, tinnitus, lightheadedness, fainting, bleeding disorders, peptic ulceration, sexually transmitted diseases, HIV."
315,STRIBILD,all-concat,"lactic acidosis, severe hepatomegaly with steatosis, death, severe acute exacerbations of hepatitis B, new onset renal impairment, worsening renal impairment, bone effects of tenofovir DF, immune reconstitution syndrome, nausea, diarrhea, ocular icterus, flatulence, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, skin discoloration, hyperpigmentation, laboratory abnormalities, AST elevation, ALT elevation, amylase increase, creatine kinase elevation, urine RBC increase, proteinuria, serum creatinine increase, eGFR decrease, renal tubular dysfunction, bone mineral density decrease, bone fractures, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia, redistribution/accumulation of body fat, cushingoid appearance, immune reconstitution inflammatory syndrome (IRIS), autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
316,TAFINLAR,all-concat,"new primary malignancies, tumor promotion in BRAF wild-type melanoma, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, embryofetal toxicity, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, myalgia, neoplasms benign, malignant, and unspecified (including cysts and polyps), cuSCC, respiratory, thoracic, and mediastinal disorders, cough, gastrointestinal disorders, constipation, infections and infestations, nasopharyngitis, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperhidrosis, hypertension, dehydration, insomnia, hemorrhage, urinary tract infection, renal failure, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, hyperglycemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, retinal vein occlusion, interstitial lung disease, retinal pigment epithelial detachment (RPED), uveitis, iritis, death."
317,TANZEUM,all-concat,"Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Upper respiratory tract infection, Diarrhea, Nausea, Injection site reaction, Cough, Back pain, Arthralgia, Sinusitis, Influenza, Vomiting, Gastroesophageal reflux disease, Dyspepsia, Constipation, Injection site hematoma, Injection site erythema, Injection site rash, Injection site hypersensitivity, Injection site hemorrhage, Injection site pruritus, Pneumonia, Atrial fibrillation, Atrial flutter, Appendicitis, Liver enzyme abnormalities, Gamma glutamyltransferase increase, Heart rate increase, Death"
318,TECFIDERA,all-concat,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albuminuria, erythema, dyspepsia, increased aspartate aminotransferase, eosinophilia, death"
319,TEFLARO,all-concat,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis, death"
320,TIVICAY,all-concat,"hypersensitivity reactions, serum liver biochemistries alterations, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, transaminase elevations, liver injury, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response, opportunistic infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
321,TOVIAZ,all-concat,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, angina, chest pain, gastroenteritis, QT prolongation on ECG, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation, death"
322,TREANDA,all-concat,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, CLL, NHL, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, fatigue, malaise, weakness, dry mouth, somnolence, cough, constipation, headache, mucosal inflammation, stomatitis, hypertension, hypertensive crisis, hypersensitivity, gastrointestinal disorders, diarrhea, general disorders, administration site conditions, immune system disorders, nasopharyngitis, infection, herpes simplex, investigations, weight decreased, metabolism and nutrition disorders, hyperuricemia, respiratory disorders, thoracic disorders, mediastinal disorders, skin and subcutaneous tissue disorders, pruritus, hematology laboratory abnormalities, bilirubin elevations, increased AST, increased ALT, creatinine levels, cardiac disorders, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal pain upper, abdominal distension, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, febrile neutropenia, oral candidiasis, anorexia, dehydration, hypokalemia, musculoskeletal disorders, connective tissue disorders, back pain, arthralgia, pain in extremity, bone pain, nervous system disorders, dizziness, dysgeusia, psychiatric disorders, insomnia, anxiety, depression, pharyngolaryngeal pain, wheezing, nasal congestion, night sweats, hyperhidrosis, vascular disorders, hypotension, anaphylaxis, injection site reactions, phlebitis, irritation, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), embryo-fetal toxicity, myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, acute renal failure, cardiac failure, pulmonary fibrosis, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, death."
323,TRULICITY,all-concat,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, Nausea, Diarrhea, Vomiting, Abdominal Pain, Decreased Appetite, Dyspepsia, Fatigue, Gastrointestinal Adverse Reactions, Constipation, Flatulence, Abdominal Distension, Gastroesophageal Reflux Disease, Eructation, Documented Symptomatic Hypoglycemia, Severe Hypoglycemia, Heart Rate Increase, Tachycardia, Sinus Tachycardia, Immunogenicity, Systemic Hypersensitivity, Injection-site Reactions, PR Interval Prolongation, First Degree Atrioventricular Block, Amylase Increase, Lipase Increase, Medullary Thyroid Carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)"
324,TUDORZA,all-concat,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching, death"
325,ULESFIA,all-concat,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation, neonatal toxicity, gasping syndrome, metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, contact dermatitis"
326,ULORIC,all-concat,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, twitching, tightness, weakness, musculoskeletal pain, stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure (some fatal), jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, death."
327,VICTRELIS,all-concat,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, embryofetal toxicity, death"
328,VIMIZIM,all-concat,"anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, retching, peripheral edema, acute respiratory complications, sleep apnea, spinal or cervical cord compression (SCC), back pain, paralysis, urinary incontinence, fecal incontinence, death"
329,VIZAMYL,all-concat,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, hypersensitivity reactions, image interpretation errors, radiation risk, cancer"
330,VORAXAZE,all-concat,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, death"
331,XALKORI,all-concat,"hepatotoxicity, Interstitial Lung Disease, ILD, Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, death, nausea, elevated transaminases, hepatotoxicity, Electrocardiogram QT prolonged, Vision disorder, Vomiting, Diarrhea, Constipation, Dyspepsia, Dysphagia, Abdominal pain, Pyrexia, Upper respiratory infection, Weight increased, Pain in extremity, Muscle spasm, Dizziness, Dysgeusia, Headache, fatigue, neuropathy, gait disturbance, hypoaesthesia, muscular weakness, neuralgia, neuropathy peripheral, paraesthesia, peripheral sensory neuropathy, polyneuropathy, sensory disturbance, rash, renal cyst, ILD, pneumonitis, syncope, Neutropenia, Lymphopenia, ALT elevation, AST elevation, Hypophosphatemia, pneumonia, acute respiratory distress syndrome, arrhythmia, respiratory failure, sepsis, alanine aminotransferase elevation, QTc prolongation, neutropenia, Hypokalemia, visual impairment, photopsia, blurred vision, vitreous floaters, Vision disorder, sensory neuropathy, dysesthesia, hypoesthesia, peripheral neuropathy, parasthesia, peripheral sensory neuropathy, burning sensation in skin, hepatic failure, Embryofetal Toxicity, fetal harm, embryotoxicity, fetotoxicity."
332,XEOMIN,all-concat,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscular weakness, muscle spasm, dysarthria, myalgia, death"
333,XIAFLEX,all-concat,"tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, swelling of the injected hand, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, pruritus, lymphadenopathy, axillary mass, tenderness, injection site swelling, injection site edema, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, finger extension procedures, flexor tendon rupture, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin laceration (tear), blood blister, injection site hematoma, ecchymosis, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, severe injection site hematoma, penile ""popping"" sounds or sensations, anaphylaxis, ecchymosis/contusion, injection site hemorrhage, penile ecchymosis, death"
334,XTANDI,all-concat,"seizure, asthenia, fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness, vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract infection, lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, death"
335,YERVOY,all-concat,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, intestinal perforation, hepatotoxicity, Stevens-Johnson syndrome, toxic epidermal necrolysis, full thickness dermal ulceration, necrotic manifestations, bullous manifestations, hemorrhagic manifestations, peripheral motor neuropathy, Guillain-Barre syndrome, myasthenia gravis, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy, encephalitis, myositis, polymyositis, ocular myositis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), death"
336,ZERBAXA,all-concat,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, cardiac disorders, tachycardia, angina pectoris, gastrointestinal disorders, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, general disorders and administration site conditions, infusion site reactions, infections and infestations, candidiasis, oropharyngeal, fungal urinary tract infection, investigations, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, metabolism and nutrition disorders, hyperglycemia, hypomagnesemia, hypophosphatemia, nervous system disorders, ischemic stroke, respiratory, thoracic and mediastinal disorders, dyspnea, skin and subcutaneous tissue disorders, urticaria, vascular disorders, venous thrombosis, death"
337,ZYDELIG,all-concat,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, sepsis, febrile neutropenia, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased, death"
338,ZYKADIA,all-concat,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Embryofetal Toxicity, Diarrhea, Nausea, Elevated Transaminases, Vomiting, Abdominal Pain, Fatigue, Decreased Appetite, Constipation, Convulsion, Pneumonia, Dyspnea, Dehydration, Respiratory Failure, Pneumothorax, Gastric Hemorrhage, General Physical Health Deterioration, Pulmonary Tuberculosis, Cardiac Tamponade, Sepsis, Hemoglobin Decreased, Alanine Transaminase Increased, Aspartate Transaminase Increased, Creatinine Increased, Glucose Increased, Phosphate Decreased, Lipase Increased, Bilirubin Increased, Neuropathy, Vision Disorder, Prolonged QT Interval, Death"
339,ZYTIGA,all-concat,"hypertension, hypokalemia, fluid retention, mineralocorticoid excess, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, cardiac failure, myocardial ischemia, myocardial infarction, non-infectious pneumonitis, myopathy, rhabdomyolysis, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, death"
